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A COMPARATIVE STUDY OF RAPID  IMMUNO 
CHROMATOGRAPHY  TEST  WITH  ELISA  FOR  DETECTION  
OF  DENGUE  NS1 ANTIGEN ,IGM  AND  IGG  ANTIBODY. 
 
Aim 
       To analyse the efficacy of Immunochromatography with ELISA for 
detection of Dengue parameters (NS1 antigen, IgM and IgG antibodies) in 
Dengue suspected cases. 
Materials and Methods 
        A total of 100  blood samples  obtained  from adults with fever >4 days 
presenting with thrombocytopaenia (<1,00,000)  were taken for the study 
from the Department of Medicine, Government Medical College Hospital, 
Tirunelveli after obtaining informed written consent. The samples were  
tested  by  Rapid Immunochromatography (ICT) and ELISA  methods  for 
NS1 Ag, IgM and IgG Ab  and  the  results  were  evaluated  for  efficacy.  
Results   
        Out of 100 adults tested by rapid ICT, 38% were positive for Dengue 
infection(NS1 antigen, IgM and  IgG  antibodies)in the serum sample. The 
same samples were tested by ELISA (Positive for any one  of the  three 
parameters)the  positivity  was found to be 59%. 37 samples  positive by 
ICT were positive by  ELISA also. Rapid ICT had a sensitivity of 87.5%, 
Specificity of 98.8%  for  NS1  antigen  when evaluated against NS1 antigen  
ELISA as gold standard.Rapid ICT had a  very  low sensitivity of 28.6% 
and 47.1%  and  an excellent specificity of 98% and 100%   for  IgM  and  
IgG antibody  detection when evaluated against MAC ELISA and  GAC  
ELISA as gold standard respectively.13.6%  showed  primary  infection  
and  64.4%  showed secondary infection. 
Conclusion  
               Out  of  the total 100 cases  studied,the rapid 
immunochromatography test has very less sensitivity and specificity is 
satisfactory .All  samples  should be subjected  to  both  antigen(NS1) and  
antibody (IgM  and  IgG) testing  to  increase  the  positivity   rate  and  to  
prevent  the  positive cases being missed. Cases with higher degrees of  
suspicion  are to  be subjected to diagnostic  tests with higher sensitivity & 
specificity  like  ELISA  and  PCR. The commercially available rapid 
immunochromatographic test device can be used as a screening device 
during Dengue outbreaks. It should not be used as a standalone device for 
diagnosis of Dengue. Further molecular studies are essential  to know the  
accurate information of  Dengue serotypes which will be helpful in 
formulating vaccines in future. 
Key words : Dengue, Immunochromatography, ELISA, NS1 Antigen, IgM 
and IgG Antibodies. 
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1.INTRODUCTION 
 
        Dengue is the most rapidly spreading mosquito-borne viral disease in  
tropical and subtropical regions of the world  caused by the bite of Aedes 
mosquito 
1
. Dengue virus belongs to the broad group Arboviruses, family 
Flaviviridae, subfamily Flavivirinae and genus Flaviviruses. Dengue virus 
has a positive sense, ssRNA viral genome. It is becoming a global public 
health emergency
1
.Though disease is usually seen in endemic areas, many 
epidemics involving continents and pandemics have been witnessed by the 
world. One such epidemic was being experienced in India while this study 
was being performed. Pertaining to weak immunity, this disease usually 
affects children. But nowadays, large numbers of adult cases are also being 
seen.   
        Dengue manifests in three forms, Dengue Fever (DF), Dengue 
Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS). A full 
spectrum of disease  ranging from a subclinical infection toa mild self 
limiting disease, the Dengue fever (DF) and a severe disease that may be 
fatal, the Dengue haemorrhagic fever/Dengue shock syndrome (DHF/DSS)  
is caused by all the four serotypes (DEN 1-4)   . The WHO 2009 
classification divides Dengue fever into two groups: uncomplicated and 
severe. Four main characteristic manifestations of Dengue illness are (i) 
continuous high fever lasting 2-7 days; (ii) haemorrhagic tendency as 
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shown by a positive tourniquet test, petechiae or epistaxis; (iii) 
thrombocytopenia  and (iv) evidence of plasma leakage manifested by 
haemoconcentration , pleural effusion and ascites, etc .DSS being the most 
serious form of illness. 
          Some 1.8 billion (more than 70%) of the population at risk for 
Dengue worldwide live in member states of the WHO South-East Asia 
Region and Western Pacific Region, which bear nearly 75% of the current 
global disease burden due to Dengue.  It causes high mortality during the 
early phases of outbreaks . The Asia Pacific Dengue Strategic Plan for both 
regions (2008--2015) has been prepared in discussion with member 
countries and development partners in response to the increasing risk from 
Dengue. This  strategic plan aims to aid countries to reverse the rising trend 
of Dengue(1). Based on this, the present study is aimed to detect, 
characterize and contain outbreaks rapidly and to stop the spread to new 
areas. 
          In 2013, Dengue ranks the most important mosquito-borne viral 
disease in the world.Dengue outbreaks put forth a huge burden on 
populations, health systems and economies in most tropical countries of the 
world. The emergence and spread of all four serotypes of Dengue viruses 
from Asia to the Americas, Africa and the Eastern Mediterranean regions 
represent a global pandemic threat. 
3 
 
       The incidence of Dengue has increased 30-fold during the past five 
decades. Some 50–100 million new infections are estimated to occur 
annually in more than 100 endemic countries, with a documented further 
spread to previously unaffected areas
2
.The true numbers are probably far 
worse, since severe under reporting and misclassification of Dengue cases 
have been documented
3
. 
        The Dengue virus is found in serum or plasma, circulating blood cells 
and selected tissues especially those of the immune system ,after the onset 
of illness ( 2 to 7 days), roughly corresponding to the period of the fever
4
. 
Dengue diagnosis is achieved either by virus isolation or by viral RNA 
identification through RT-PCR or by serological detection of Dengue 
specific IgM and IgG antibodies .Virus isolation and RT- PCR are time 
consuming and costly laboratory methods .Thus detection of Dengue 
antigen or antibodies is feasible for diagnosing Dengue  in most cases. NS1 
antigen is a hexameric form of Dengue virus protein was found circulating 
in the sera of patients during the acute phase of the illness. Detection of 
Dengue NS1 antigen indicates early Dengue infection
2
. 
           Since viral isolation is laborious, expensive and is only available in 
reference laboratories, serological diagnosis remains the mainstay of 
diagnosis during the epidemic. Serological detection of antibodies based on 
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capture ELISA has become the new gold standard for the detection of 
Dengue virus infections
5
.   
        Early diagnosis is useful in triaging patients and have a central role in 
Dengue case management and plays a vital role in forecasting an early 
warning of an epidemic and in undertaking effective vector control 
measures. 
       Since there is no specific antiviral therapy or immune prophylaxis  
available, timely and rapid diagnosis plays a vital role in patient 
management and implementation of control measures . Rapid assessment 
with a balanced reliability is of great importance in peripheral health 
settings where  the present study was being conducted.  
       In this context, this study was carried out to evaluate the performance of 
a rapid immunochromatographic test device for the detection of IgM, IgG 
antibodies and NS1 antigen to Dengue infection against the serological 
detection of antibodies based on capture IgM ,IgG ELISA  and detection of 
antigen  by  NS1 ELISA  was taken as the reference standard. 
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2.AIM AND OBJECTIVES 
 To detect Dengue specific NS1 antigen ,IgM and IgG antibodies by 
Enzyme Immunosorbent Assay (ELISA). 
 To detect Dengue NS1 antigen ,IgM and IgG antibodies by rapid  
Immuno-chromatographic (IC) card test. 
 Comparison of two diagnostic tests for early/rapid diagnosis of acute 
Dengue infection.  
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                                    3. REVIEW OF LITERATURE 
 
3.1 HISTORY 
       The word Dengue was derived from Swahili phrase „Ki-dinga pepo‟, 
meaning “cramp-like seizure caused by an evil spirit‟. In Spanish ,“Dengue” 
means fastidious or careful, which describes the  gait  of  a  person suffering  
bone pain due to Dengue fever .The disease was also known as “Dandy 
fever” in slaves of West Indies. The first case of probable Dengue fever was 
recorded in a Chinese medical encyclopedia from the Jin Dynasty (265 – 
420 AD) which referred to a “water poison” associated with flying 
insects
6.
The term ‘break bone fever‟ was coined during the Philadelphia 
epidemic in 1780, by Benjamin Rush because of the symptoms of  
myalgia& arthralgia
7
. 
          The  viral  etiology  and  the  transmission  by  the  mosquitoes  were 
deciphered in  the 20th century. During 1944 to 1956, it was shown that 
same clinical syndrome was caused by four distinct types of viruses. DEN1 
was first isolated from Hawaii in 1944, DEN2 from New Guinea also in 
1944, DEN3 & 4 from the Philippines in 1956. The other two serious forms 
of the disease, Dengue Hemorrhagic Fever(DHF) & Dengue Shock 
Syndrome (DSS) were documented for the first time in 1956 
8
. 
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3.2 PREVALANCE 
3.2.1.Global prevalence 
       The incidence of Dengue has grown dramatically around the world in 
recent decades. Over 2.5 billion people that is, around 40% of the world's 
population are now at risk from Dengue. WHO currently estimates there 
may be 50–100  million  Dengue  infections  worldwide  every  year.  
 More than 70% of the population at risk for Dengue worldwide live in 
member states of the WHO South-East Asia Region and Western Pacific 
Region, which bear nearly 75% of the current global disease burden due to 
Dengue 
1
which includes asymptomatic cases. Every year hundreds of 
thousands of severe cases arise, including 20,000 deaths
9
; 264 disability-
adjusted life years per million population  per year are lost
10
, often affecting 
very poor populations .An estimated 5,00,000 people with severe Dengue 
require hospitalization each year, a large proportion of whom are children. 
About 2.5% of those affected die 
2
. Estimates suggest that annually 100 
million cases of Dengue fever and half a million cases of Dengue  
haemorrhagic  fever(DHF) occur in the world with a case fatality in Asian 
countries  of  0.5%–3.5%.  
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Factors  Responsible  for  the  Increased Incidence  of  Dengue  
11 
 unprecedented  growth  of  population  
 unplanned  and  uncontrolled  urbanization, 
 lack  of  effective  mosquito  control  in  areas  where  Dengue  is  
endemic  
 increased  air  travel. 
 decay  in  public  health  infrastructures  in  most  countries  and  lack 
of resources. 
            A  study  was carried out  in  Bangladesh  by  Sultana N et al 
12
,  to 
find out   the seroprevalence of Dengue fever in Chittagong .Among 1181 
serum samples tested from suspected  Dengue patients, 533 (45.13%) were 
positive  for IgM  and  IgG  antibodies  by  ICT. 
3.2.2.Prevalence  in  India 
            Dengue infection is the most rapidly spreading mosquito-borne viral 
disease in the world and an estimated 50 million Dengue infections occur 
annually. Case fatality rates for the South-East Asian region are 1%, but in 
India, Indonesia  and  Myanmar, focal outbreaks  have  reported  rates  of  
3%-5% 
13.
 
The  global  epidemiology  of  Dengue  has  been  changing  during  
the  last 50  years
11
. The  number  of  countries  reporting  Dengue  has  
increased  in  recent  years  and  also  the  number  of   disease severity  in  
the  form  of  DHF/DSS  is  also  being  increasingly  reported. The  first  
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Dengue  epidemic  in  India  occurred  in  Kolkata  during 1963-64
14
 and  
ever since , the  epidemiology  of  Dengue  virus  has  been  changing . India  
is  endemic  for  Dengue , having  witnessed  several  DF/DHF  outbreaks  
in  the  last decade 
15,16
.The  last  major  DF outbreak  in  India  occurred  
between  September  and  October  2006 involving  more  than  12,000  
cases  and  nearly  184 deaths, of  which approximately  3366  cases  and  
65  deaths  were  reported  from  Delhi  alone 
17
. In 2006 the number of 
cases reported as compared to 2005 shows some reduction whereas the case 
fatality rate has remained above 1%. In 2009, in India 15535 cases were 
reported with 96 deaths while in 2010, 28292 cases of Dengue were 
reported with 110 deaths. In 2013, till   August, 22092  cases  were  reported  
with  74  deaths. 
        The case fatality rate in patients with Dengue hemorrhagic fever (DHF) 
and Dengue shock syndrome (DSS) can be as high as 44%. Hence early and 
rapid laboratory diagnosis of Dengue is vital. Appropriate clinical 
management can save the  lives  of  patients  suffering from  DHF  and  DSS 
and  mortality  can  be  reduced  to  less  than 1%. 
       According to a study conducted by Saini et al
18
, the prevalence of 
Dengue seropositivity among clinically suspected cases in a tertiary care 
hospital in Maharastra was  30.6% .  
              Recent study by Gargi ghosh et al 
21 
highlighted that out of 1782 
samples received  from  clinically  suspected  cases of Dengue  over  a  
10 
 
period  of  2  years, 320  showed  positive  by  Dengue  Rapid  
Immunochromatography  method. 
        Sharma  Y et al
19
 revealed  that  during  the  study  period (2006–
2010), a total  of  8138   serum  samples  were  tested  out  of  which, 1600 
(19.66%) were positive for Dengue  specific  IgM  antibodies  by  MAC  
ELISA.  A  similar  study  by Garg et al
20
 reported  that  the  seroprevalence  
of  Dengue  virus  infection   at  Kanpur,  North India  was 19.7% by IgM 
and IgG  anti Dengue antibody  detection   by  ELISA. 
        Manisha Patankar et al
22
 stated  that  the  seroprevalence of  Dengue in 
Gujarat  was  21%  by  NS1 ,MAC-ELISA  and  RT-PCR. 
       Chakravarti et al
23
in  2011 reported  that  the  seroprevalence  of  
Dengue infection  in  central  part  of  India  was  60.1%  tested  by  ELISA.  
      Based  on   the  study  conducted   by  SirajA.Khan et al
24
 in  a  hilly  
region  of  Andhrapradesh, out  of  164 samples, 107 (65.2%)  were  found  
to  be  Dengue  positive. 
3.2.3.Prevalence  in  Tamilnadu 
            In southern India , epidemic of  Dengue  has  been  reported  in 
Tamil Nadu,  Kerala ,Karnataka, and  Andhra Pradesh . During the past 
years, there has been an improvement in the reporting of Dengue fever cases 
in Tamil Nadu, since the laboratory diagnostic facilities have considerably 
increased. A total of 128 cases and 5 deaths were reported in 1998 which 
11 
 
increased to 1600 cases and 12 deaths  in  2003  and  1150  cases  and  8  
deaths  in  2005.
25
 
             Recent statistics as per “NVBDCP INDIA 23”  reported  that during  
2007 , a  total of  707 cases and  2 deaths were  reported  which  increased  
to 1072 cases and 7 deaths in 2009 and 2501 cases and 9 deaths in 
2011.During 2012 epidemic ,12826 cases and 66 deaths were reported 
which eventually decreased to 4294 cases and no deaths in 2013. This is 
mainly due to increase in the testing facilities in Tamil Nadu.  
          Vijayakumar et al
13
, in a  five  year  study  conducted  at  Christian  
Medical College  Vellore  reported  that  the seroprevalence  was  found  to  
be  55.1%  during  2003  tested  by  various  methods  such  as  Dengue  blot  
tests , ICT  and  IgM  capture  E LISA  assay. 
       A Chennai based  study  by P Gunasekharan et al
26
 stated that out of 
1593 samples tested ,686 (43.0%)  were  positive  for IgM antibodies 
detected  by  MAC-ELISA  and  ICT  during  a  period  of  2006-2008. 
        A Hospital based study at Perambalur conducted  by M Anuradha et 
al
27 
(2013-2014) observed that out of 151 Dengue  suspected cases , 60 were  
positive by using Dengue  ELISA  kit. The incidence of Dengue viral  
infection  was 39.74%. 
Paramasivam et al
28 
in a study  stated  that  during  an  outbreak  of  Dengue 
fever in certain rural areas of  Kanyakumari district, Tamil Nadu , out of  the 
12 
 
76 samples  tested , 15 (20%)  were  found  positive  for  Dengue  virus  
specific  IgM Antibodies  by  ELISA.   
        Based on the study  conducted by N Satish et al
29
 at a Hospital in 
Vellore, estimated  that  the  prevalence  of  Dengue  among  the  study  
population was 25%. 
3.2.4. Prevalent  serotypes  in India 
          Samples isolated from Gujarat showed that DENV2 was the 
predominant serotype during the epidemics of 1988-89 
30
. With time, 
Dengue virus outbreak reached different states of India. In 1992 Jammu also 
saw an outbreak of DENV2
31
. DENV2 serotype was isolated during an 
outbreak in Haryana as well 
32.
 DENV2 was also prevalent in Northern India 
where outbreaks were seen in Delhi, Gwalior and Lucknow
33,34
. However, 
DENV1 was the dominant serotype isolated during an outbreak in New 
Delhi 1997 
35
. The Gwalior outbreaks of 2003-04 were dominated by 
DENV3 
36,37
, and  was also prominent in 2004-05 
38
. This co-circulation of 
serotypes in the same area might be the reason behind the large number of 
DHF cases reported this year 
39
. In 2006, all four serotypes of Dengue  
viruses  were  found  in  co-circulation. 
        A  study by Cecilia et al
40 
in Pune , Maharastra  reported that  from 
May 2009 to  September  2010, 56 cases was serotyped  by the multiplex  
RTPCR test. 13 cases of DENV-1, 21 of DENV-2, 20 of DENV-3 and 2 
cases  of  DENV-4  were  detected. 
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3.2.5.Recent Trends In India. 
              Rapid growth of  population and sudden climatic changes in India 
were found to contribute to the rise in DF/DHF cases 
41
. During 1997 to 
2004, the causative agent of most DF/DHF cases  was of  DENV1  serotype  
but later in 2005, DENV3 became the leading source of Dengue outbreaks
42
. 
According to the WHO in 2006, the total number of reported cases reached 
12,317, while 5,534 cases occurred in 2007 owing greatly to preventive 
measures taken by both the public and private sectors. In 2009, however, DF 
cases again reached 11,476 by November. The first cases were reported in 
July 2009 with the greatest number of cases seen in October. These trends 
demonstrate that DENV has penetrated deep into India, with DENV2 and 
DENV3  predominating  among  different  DENV  serotypes.  
3.2.6.Prevalent serotypes in Tamilnadu 
        The prevalence of Dengue vector and silent circulation of Dengue 
viruses have  been  detected  in  rural  and  urban  Tamil Nadu.  
         A  study  conducted  by  Bhuvaneshwari CK et al
25
 on clinically  
suspected cases of Dengue attending Thanjavur Medical College and Trichy 
Hospital (2011) revealed  that DENV ‑ 2 and DENV1 had dominated 
,although three serotypes were  found  to be co- circulating  as detected  by  
RT‑PCR. 
14 
 
         Myers RM et al
43 
during a Dengue outbreak in Vellore, southern India, 
in 1968 documented that there is circulation of all the four serotypes of the 
Dengue viruses in Tamilnadu. 
3.3. VIRION  STRUCTURE 
Flaviviruses  possess  an isometric core, 30–35 nm in diameter, that 
contains a nucleocapsid or core (C) protein complexed with single-stranded 
positive-sense RNA. This core is surrounded by a lipid bilayer containing an 
envelope (E) protein and a membrane (M) protein, giving a total virion 
diameter of about 45 nm. The flavivirus E protein is a class II fusion 
protein. The M protein is first synthesized as a precursor protein, prM. The 
virion structure of Dengue virus (DENV) virus has recently been solved 
using cryo-electron microscopy
44
. 
3.4.CLASSIFICATION  AND  GENOME  STRUCTURE  
          There  are  four  serotypes  (DEN 1–4),  classified  according  to 
biological  and  immunological criteria .The  viral  genome  is  
approximately  11 kb  in  length. It  has  been  shown  that  there  is  
abundant  genetic  variation within  each  serotype  in  the  form  of  
phylogenetically  distinct  clusters  of sequences  dubbed  subtypes  or  
genotypes .  At  present , three  subtypes  can  be identified  in  DENV-1 , 
six  in  DENV-2  ( one  of  which  is  only  found  in  non-human  primates),  
four  in  DENV-3  and  four  in  DENV-4  ( with  another exclusive  to  non-
human  primates)
45
.  The  mature  virions  consist  of  three structural               
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( core , membrane  associated , and  envelope )  and  seven  non-structural 
(NS1, NS2a, NS2b, NS3, NS4a, NS4b, and NS5) proteins. The envelope 
protein is involved in the main biological functions of the virus. It binds to 
receptors on host cells, allowing the virus to be transported through it. In 
addition, the envelope protein is associated with haemagglutination of 
erythrocytes, induction of neutralizing antibodies and protective immune 
responses. Non-structural proteins (NS1–NS5), expressed as both membrane 
associated and secretory forms, have also been implicated in the 
pathogenesis of severe disease. 
         NS1 gets expressed on the surface of infected cells. Preliminary 
evidence suggests its involvement in viral RNA replication. Plasma levels of 
secreted NS1 (sNS1) relate well with viral titre being more in DHF patients 
than DF only. Moreover, elevated free sNS1 levels within 72 hours of onset 
of illness identify patients at risk of developing DHF. Very high levels of 
NS1 protein are detected in acute phase samples from patients with 
secondary Dengue infections but not primary infections.This suggests that 
NS1 may contribute to formation of circulating immune complexes, which 
are thought to have an important role in the pathogenesis of severe Dengue 
infections. 
46
 
          A study  by Thomas et al demonstrated that the Dengue virus NS1 
was detected in 47 (67.1%) of 70 patients positive for Dengue by RT-PCR 
and it was found to be that there was increase in the plasma virus loads in 
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NS1-positive patients and  the sensitivity of NS1 testing also increased with 
virus load. 
3.5. MOSQUITO VECTORS IN DENGUE INFECTIONS 
             Dengue is transmitted by the mosquitoes belonging to the genus 
Aedes (Aedes aegypti, Aedes albopictus, and Aedes polynesiensis). A. 
aegypti is the most important vector, but A.albopictus and A.polynesiensis 
may also act as vectors depending on the geographic 
location
2
.A.albopictushas also been found to transmit Dengue in Thailand, 
India, Singapore, Samui  island  and  Mexico. Aedes aegypti, a day biting 
and a container breeding mosquito is found in tropical and subtropical 
areas
47
. They breed indoors, mainly in living rooms and bedrooms that 
increases man-vector contact and reduces the contact with insecticides 
sprayed outdoors ,thus contributing to difficulty in controlling this vector
48
. 
Aedes aegypti can breed in small collections of water such as flower vases 
or coconut shells and also in polluted water
49
. Eggs of these vectors resist 
dessication and hence they survive for long periods. The factors responsible 
for high mosquito densities in endemic areas are improper garbage disposal 
and inadequate drainage of wastewater facilitates. Both the factors are  
consequences  of  unplanned  urbanization. During the rainy season, there is 
a significant increase in the mosquito larval populations which may be a 
reason why  epidemics  of  Dengue  tend to coincide with the rainy season
50
. 
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       Ambient temperature and relative humidity also has an effect on viral 
propagation in mosquitoes; rates being highest in climates resembling the 
rainy season .Environmental temperatures also affect the time to acute 
viraemia in female mosquitoes, being  shorter  with  rises  in  temperature 
51
. 
       After biting an infected human, Dengue viruses enter an adult female 
mosquito following which it replicates in the midgut, reaches the haemocoel 
and haemolymph, and then gain its entry to different tissues of the insect. 
After viral replication in the salivary glands, the infected mosquito transmits 
the virus to another human. Viral particles are shown within the epidermal 
cells ,nervous system, salivary glands, foregut, midgut, ovary and internal 
body wall lining cells of the mosquito  by  ultrastructural  studies .In 
contrast, they are found to be absent from the muscle, the hindgut, and  
malphigian  tubules. Infected mosquitoes take longer time to complete a 
blood meal when compared to uninfected one which contributes to the 
efficiency of A .aegypti as a Dengue viral vector. This increased time 
corresponds to Dengue virus infection of organs known to control or  
influence  activities  associated  with  feeding
52
. 
           Several studies suggest the existence of transovarial Dengue virus 
transmission in Aedes infected female mosquitoes, allowing propagation of 
virus to their progeny. Such a process would allow it to act as a reservoir for 
virus maintenance during  inter epidemic  periods (without human or other 
vertebral host participation)
53
.Reports also suggest that Dengue viruses may 
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be transmitted sexually from the male to female mosquitoes, but not vice 
versa
54
. 
3.6.PATHOGENESIS  OF  DENGUE FEVER/DHF
27
 
         Dengue is caused by anyone of the Dengue viral serotypes. In general, 
infection with one serotype gives protective immunity against that particular 
serotype but not against other serotypes in future. More severe form of 
infection occurs when infected for a second time with a different serotype. 
This phenomenon is as a result of a process known as antibody dependent 
enhancement, where antibodies against the first serotype boost up the 
infection with the second serotype .Only 2–4% of individuals with a 
secondary Dengue infection develop severe disease
55
.                                              
       When an infected mosquito bites,the Dengue virus enters the body and 
replicates within cells of the mononuclear phagocyte lineage(monocytes, 
macrophages and B cells). In addition, infection also involves the mast cells, 
dendritic cells, and endothelial cells. Dengue infection has an incubation 
period of 7–10 days followed by a viraemic phase where the patient 
becomes febrile and infective .Subsequently ,the patient may either recover 
or progress to the leakage phase ultimately leading to DHF and/or DSS. 
Severity of Dengue infections correlates with the peak plasma viraemia . 
Patients with uncomplicated Dengue fever or DHF/Dengue shock syndrome 
show differences in antibody, cytokine, and T-cell responses . 
 
19 
 
3.6.1.Antibody  responses  to  the  Dengue  virus . 
       Antibody dependent enhancement plays a crucial role in the 
pathogenesis of severe Dengue infections. During secondary Dengue 
infections, antibodies that is already present in the patient form complexes 
with the Dengue virus. The Fc portion of these antibodies bind to FccRI and 
FccRII possessing cells and results in  increased number of cells being 
infected by the Dengue virus. Antibody dependent enhancement occur only 
in the presence of subneutralizing concentrations of antibodies to Dengue 
virus 
56,57
. 
3.6.2.Cytokine  responses  in  Dengue infections. 
        During the initial 3 days high levels of TNF-α, IL-2, IL-6 and IFN-γ 
are seen. IL-13 and IL-18 is increased during severe infection. Cytokines 
IL-2 and IFN-γ are of Th1 type and IL-5 and IL-4 are of Th2 type. Thus, 
Th1 responses are seen during the first 3 days and Th2 responses occur later 
.During severe Dengue infections, increased levels of IL-13 and IL-18 have 
also been reported, with highest levels seen in patients with grade IV DHF. 
Serum IL-12 levels are increased in patients with Dengue fever, but in 
patients with grade III and IV DHF,the level becomes undetectable. TNF-α, 
IL-6, IL-13, IL-18, and cytotoxic factor  levels are increased in patients with 
DHF when compared to patients with DF
 58,59
.These cytokines have a key 
role in causing increased vascular permeability  and shock during Dengue 
infections
60
.High levels of TNF-α correlate with haemorrhagic 
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manifestations . Increased levels of  IL-10 correlates with  platelet decay 
and  in addition it  down regulates  platelet function contributing to  platelet  
defects  that  are  associated  with  Dengue infections. 
3.6.3.Cellular  immune  responses  in  Dengue  infections 
            In  Dengue fever and DHF ,suppression of T-cell responses can 
occurs which persists for at least two weeks after the onset of fever
61
. In one 
study, 6% of patients presents with respiratory tract infections or diarrhoea 
after Dengue infections. This suppression was found to be due to a primary 
defect within antigen presenting cells. As the levels of IL-10 are increased 
in DHF, they downregulate antigen  presenting  cell  responses  and  induce  
unresponsiveness  in  T-cells. 
3.7.CLINICAL FEATURES 
              Infection with Dengue virus may be subclinical or may cause 
illness ranging from a mild undifferentiated fever to a severe, life-
threatening condition (DHF or DSS). The symptoms lasts for more than a 
week and even longer in some patients.  
3.7.1.Undifferentiated fever 
       This usually follows a primary infection but may also occur during 
the early phase of a secondary infection. Clinically it mimics many other 
viral infections and is frequently not diagnosed. 
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3.7.2.Dengue fever 
        Dengue fever is most commonly seen in adults and older children. It 
occurs during both primary and secondary infections. Typically symptoms 
start with sudden onset of high fever, which could be biphasic lasting 3 to 7 
days 
62,63 
associated with chills ,rigor and intense headache (especially 
behind the eyes),fatigue ,muscle and joint pain (ankles ,knees and elbows) 
,unpleasant metallic taste in mouth ,loss of appetite, vomiting, diarrhea and 
abdominal pain .Dermatological manifestations presents as flushed skin on 
face and neck, macular papular  rash on the arms and legs with severe 
itching and peeling of skin and  hair loss .Young patients may present with 
coryza , diarrhea, rash, seizure, vomiting, headache, and  abdominal pain
64
. 
        Hemorrhagic manifestations are uncommon in Dengue fever. However, 
minor bleeding (nose or gums), heavy menstrual periods, petechiae/purpura, 
gastrointestinal bleeding may be seen 
65,66
. 
          A positive tourniquet test has been reported in many individuals with 
Dengue fever 
67
. Recovery from Dengue fever is usually uneventful, but 
may be prolonged especially in adults 
2
. 
3.7.3.Dengue hemorrhagic fever 
          Dengue hemorrhagic fever (DHF) usually follows a secondary 
Dengue infection. In infants, it may follow a primary infection due to 
maternally acquired Dengue antibodies 
68
. Typically, DHF is characterized 
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by high fever, hemorrhagic phenomena, features of  circulatory  failure  and  
hepatomegaly 
69
. 
 DHF is divided into four grades according to severity. 
3.7.3.1.Grading of Dengue hemorrhagic fever 
Grade 
I  No shock, only positive tourniquet test 
II   No shock, has spontaneous bleeding other  than  a  positive tourniquet 
test 
III   Shock 
IV    Profound shock  with   un-measurable  blood  pressure  and/or  pulse. 
The clinical course of DHF is divided into three phases, namely,  
 febrile phase 
 leakage phase  and 
 convalescent phase.  
        The febrile phase begins with sudden onset of fever - lasts for 2-7 
days usually high grade (39°C), intermittent and associated with rigors 
accompanied by generalized constitutional symptoms, facial flush, rash and 
bleeding manifestations.The liver is often enlarged, soft and tender but 
jaundice is not observed. Splenomegaly is rarely observed in small infants 
.Generalized  lymphadenopathy  is  noted   in  about half  of   the  cases. 
Plasma leakage phase /critical phase  is characterized by tachycardia 
and hypotension ,sweating and restlessness ,cold extremities ,pleural 
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effusions (usually right side) and ascites
70
. Thrombocytopenia and  
hemoconcentration are detectable before  the  subsidence  of  fever  and  the  
onset  of  shock. 
     Hemorrhagic manifestations occur after fever has settled
68
.The 
commonest site being gastrointestinal tract (which manifests as 
hematemesis or melena) followed by epistaxis
71
.Vaginal bleeding has been 
reported in females despite high platelet counts.Complications such as 
pericardial effusions, myocarditis occur that is associated with increased 
morbidity and mortality.  In less severe cases of plasma leakage, patients 
recover spontaneously after a short period of fluid and electrolyte 
replacement. In severe cases with high plasma leakage, patients may 
develop full blown circulatory shock characterized by prolonged capillary 
refill time and narrow pulse pressures. Convalescent phase is characterized 
by bradycardia ,confluent  petechial  rash  with  erythema  and  pallor . 
  A one year study conducted by Nizal MG et al
72 
analyzed that among 
1466 cases of Dengue  , 1342 (91.5%) cases  were  Dengue fever  and  the 
remaining 124 (8.5%) were  Dengue  hemorrhagic fever in Neger 
Sembilan,Malaysia  in 2010. 
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3.7.4.Dengue  shock  syndrome 
         Presents with tachycardia, hypotension ,cold blotchy skin, congested 
peripheries and  circumoral  cyanosis. It is important to distinguish DSS 
from septic  shock  to  avoid  inappropriate  use of  antibiotics
73
.  Patients  
with  DSS die  due  to  multiorgan  dysfunction  and  disseminated   
intravascular coagulation.DSS  is  associated  with  very  high mortality 
(9.3-47%) .DSS may be accompanied by encephalopathy due to metabolic 
or electrolyte disturbances. Adequate urine output and the return of appetite 
are considered to be good prognostic signs.  
           A Hospital based  5 year study in New Delhi by Sharma Y et 
al
19
revealed that out of the total 1600 cases admitted  between 2006 and 
2010, 279 (58.9%) had DF, 178 (37.6%) had Dengue hemorrhagic fever, 
and 16 (3.38%) had Dengue shock syndrome. 
3.7.5.The differential diagnosis of Dengue fever and DHF 
Dengue fever: Infectious mononucleosis, Chikungunya viral Infections, 
Coxsackie and other enteroviral infections, Rickettsial infections, Rubella, 
Parovirus B19 infections  ,Influenza , Leptospirosis etc… 
DHF : Leptospirosis, Chikungunya viral infections, Hanta viral infections, 
other hemorrhagic fever, Meningococcal septicemia, Yellow 
fever,Kawasaki disease etc….. 
         Singh NP et al 
74
observed that fever was present in all the cases with 
an average duration of 4.5±1.2days with headache (61.6%), vomiting 
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(50.8%) backache (57.8%) and abdominal pain (21%) being the other 
presenting complaints. Hemorrhagic  manifestations  in  the  form of  a  
positive  tourniquet test (21%), gum bleeding and epistaxis (40%), 
hematemesis (22%), melena (14%) and skin rashes (20%) were  also 
observed. Hepatomegaly and  splenomegaly  were observed in 10% and 5% 
of cases, respectively. Laboratory investigations revealed thrombocytopenia 
(platelet count of <100,000 /µl)  in 61.39%of cases, hemoconcentration 
(Hct>20% of expected for age and sex) and leucopenia (WBC <3,000/mm2)  
were  observed  in  68%  and  52%  of  the  cases, respectively.  
          A recent study by Gargi Ghosh et al
21
proposed  that 71% of the 
patients presented  with  only fever  with  chills , followed  by  fever  with  
chills  and rashes 13%, fever with chills and arthralgia 5% and fever with 
myalgia 3%. Sub-conjunctiva lhaemorrhage, a  presumptive  sign  of  DHS 
was seen only in 2% of the patients  in  this  study  whereas  the  rest  
showed  other  insignificant  associated signs  and  symptoms. 
3.8.RISK  FACTORS 
3.8.1.Age 
         DF is considered as a childhood disease and is an most important 
cause of paediatric hospitalization in Southeast Asia .However, in India, DF 
affects all age groups. 
Gubler et al 
11
 studied  that Dengue affects  all age  groups  worldwide and  
poses  a  pediatric  public  health  threat  in  some  parts  of  the  world. 
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 Based on the study by Sumitasood et al 
75
,the  mean age group that 
was mostly affected in the study was the 16-30 years .  
 Sharmila et al
76 
stated that the age wise distribution of IgM positive 
cases in  three  year  study  indicates that children (<10 yrs) were more 
commonly affected. 
 According  to  a study by Garg et al
20 
among clinically suspected 
fever cases at a teaching hospital in North India reported that the most 
affected age group was 0 to 15 years of age (Pediatric  population), followed 
by 16 to 30 years group. 
3.8.2. Sex 
 A study by Ekta gupta et al
77 
revealed that in overall  DF/DHF cases 
males predominated over females(M: F ratio) .Year wise distribution of 
Dengue cases shows  that  males  were  more  frequently  affected  when  
compared  to  females. 
 Smitasood et al
76
reported that a higher prevalence of Dengue 
infection was found in males than in females ,the ratio being  2.43:1. 
 Khan et al
78
 revealed that female patients comprised 67.2% of the 
positive  cases  when compared to males in a hilly region in Arunachal 
Pradesh . A similar study was carried in Kolkata by Sarkar D et al
79
observed  
that females are more affected  than  males
. 
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3.8.3.Climatic  Factors 
            Study by Gargi ghosh et al
21 
revealed that there was a peaking of 
serologically positive case from July to October in each of the years of the 
study. The peak incidence of Dengue cases in a study by EktaGupta  et 
al
77
,(2006)  was in the 2nd and 3rd week of October.  A study by Saini et 
al
18 
observed that the transmission of Dengue virus infection increases in 
post monsoon period . This is mainly due to the presence of stagnant water 
after rain fall which favours the breeding of mosquito. There was also a 
increase of cases during the month of May which may be due to severe 
drought in the area that year and people have tendency to store the water for 
long period. 
           Based  on  the  study  by  Sharma et al 
19
, prevalence  of  Dengue for 
the past  5 years  reported  that  there  is an increase in the number of cases 
from  July to October that is during monsoon and post-monsoon period 
every year , confirming  the  active  transmission  period. 
3.8.4.Socio-demographic factors 
         Yadava  and Narasimaham et al 
80
, 1992  stated that the disease was 
mainly restricted to urban and semi-urban areas of the country  earlier 
because of the availability of favourable sites for breeding of the mosquito 
vector species, A. aegypti, .Thus ,rural areas were found to be largely free of 
the vector species . 
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Rakesh et al
81
,1997 observed that  introduction of safe drinking water 
in rural areas  led to water storage practices providing breeding sites for 
vectors . 
3.8.5.Travellers 
          In a study to estimate the incidence and prevalence of Dengue virus 
infection in Australian travellers to Asia Ratnam et al 
82
reported the 
incidence of 3.4 infections per 10,000 days of travel and  seroprevalence of 
Dengue infection was 4.4% and a greater number of prior trips to Asia was a 
predictor for Dengue seroprevalence  detected  by IgM and IgG ELISA. All 
travellers experienced subclinical Dengue infections and had travelled to 
India and China . This significant attack rate of Dengue infection can be 
used  to  advise  prospective  travellers to Dengue-endemic countries. 
3.9.LABORATORY  DIAGNOSIS  AND  DIAGNOSTIC  TESTS. 
             Accurate and efficient diagnosis of Dengue is of main importance 
for early detection ,case confirmation , differential diagnosis with other 
infectious diseases, outbreak control, pathogenesis, academic research, 
surveillance activities ,vaccine development and clinical trials. Dengue virus 
infection can be confirmed by various laboratory diagnostic methods. This 
involves virus isolation and identification, detection of viral nucleic acid, 
antigens or antibodies, or a combination of these techniques. After the onset 
of infection, the virus are found to be detected in serum, plasma, circulating 
blood cells and other tissues for 4–5 days.Virus isolation, nucleic acid or 
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antigen detection can be used in the diagnosis of infection during the early 
stages of the disease but  serology is the method of choice at the end of the 
acute phase of infection.  
              Depending on the host‟s immune status, antibody response to 
infection differs 
82
. When a person who have not been infected previously 
with flavivirus or immunized with a flavivirus vaccine (e.g. for Japanese 
encephalitis, yellow fever, tick-borne encephalitis) ,develops primary 
antibody response if the person is being subsequently infected with Dengue 
virus. This primary response is characterized by a slow increase of specific 
antibodies. The first immunoglobulin to appear are IgM antibodies .These 
antibodies are detectable in 50% of patients in 3-5 days after  the onset of 
illness, increasing to 80% by 5
th
 day and 99% by day 10 . IgM levels  
reaches its peak  in about two weeks after the onset of symptoms and then 
declines  to undetectable levels over  a period of 2–3 months.  
              In general, serum  IgG antibodies is detectable at low titres at the 
end of the first week of illness. Thereafter ,it increases slowly, with serum 
IgG still detectable after several months, and may be even for life 
83,84
. In a 
secondary Dengue infection, there is a rapid rise in antibody titre which 
react against many flaviviruses. IgG isotype is the dominant 
immunoglobulin detectable at high levels, even in the acute phase the 
infection .IgG are found to persists for periods lasting from 10 months to 
life.  Early convalescent stage IgM levels are significantly lower in 
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secondary infections than in primary ones and may be undetectable in some 
cases, depending on the test used 
85
.  
 Kuno G et al
86
, Shu PY et al
87
and Falconaret al
88
observed that to 
distinguish primary and secondary Dengue infections, IgM/IgG antibody 
ratios are more commonly used now than the haemagglutination -inhibition 
test. 
 A range of laboratory diagnostic methods are available to support 
management of patient and control of disease. The choice of diagnostic 
method depends on the purpose of the test for which it is done, the type of 
laboratory facilities and availability of technical expertise, costs, and the 
time of sample collection. 
 Generally, tests with high sensitivity and specificity are technically 
more complex and requires technical expertise, whereas rapid tests may 
compromise sensitivity and specificity for the ease of performance and 
speed. Although virus isolation and nucleic acid detection are more specific 
than serologic methods for antibody detection ,they are found to be more  
labour-intensive and costly.                   
Methods used for diagnosis of Dengue infections are: 
1. Virus isolation 
2. Viral nucleic acid detection 
3. Serological methods 
 Haemagglutination inhibition (HI) 
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 ELISA 
 Immunochromatography 
 Neutralization test (NT)  
 Complement fixation (CF) 
4. Viral antigen detection 
3.8.1. Virus isolation and identification. 
Detection of Dengue virus by culture is the definitive diagnostic 
test.Its practical considerations limit its use. Dengue virus can be isolated 
from serum, plasma, circulating blood cells like leucocytes and also be 
isolated from postmortem specimens such as liver, lung, spleen, lymph 
nodes, thymus, cerebrospinal fluid and pleural/ascitic fluid. Blood should be 
collected during the febrile period, if possible before the fifth day of illness 
before the formation of neutralizing antibodies.Immune complex formation 
in secondary Dengue patients is due to the presence of large quantities of 
neutralizing antibodies which interferes with virus isolation. Serum can be 
placed at 4–8° for  a short  time  if less than 24 hours.  
      Race MW et al
89 
and Singh KRP et al
90
 reported that the mosquito 
cell line C6/36 ,a clone obtained from Ae. albopictus has become the choice 
of host cell used for routine Dengue virus isolation and in addition, cell line 
obtained  from Ae.pseudoscutellaris AP61 can also been used successfully.  
Cordeiro M.T et al
91 
reported that mammalian cell cultures like Vero cells, 
LLCMK2 and others have also been employed , but with less efficiency. 
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Henchal EA et al
92
 observed that  Dengue virus in general is identified using 
immunofluorescence techniques with serotype-specific monoclonal anti-
Dengue antibodies on mosquito head squashes or infected cells.Some strains 
of  the virus ,when present in low concentration cannot be easily identified. 
Plaque assay is considered as the gold standard methodology for Dengue 
virus quantification.  
    Payne et al
93
proposed that an indirect immunofluorescence assay can be 
used as an alternative to virus culture. Kao Clet al
94 
reported that Flow 
cytometry has recently been a useful method for Dengue virus 1 (DEN-1) 
identification and allows the virus to be detected 10 hours earlier than with 
an immunofluorescence assay by using an anti nonstructural glycoprotein 
(NS1) monoclonal antibody. 
3.8.2. Viral nucleic acid detection: 
Dengue viral genome, which possess RNA, can be detected by 
reverse transcriptase polymerase chain reaction (RT – PCR) assay.It offers 
better specificity and sensitivity when compared to virus isolation with a 
advantage of more rapid turnaround time. But again the high cost and 
requirement of technical expertise is the question n the utility of PCR. 
Lanciotti et al
95
developed that some laboratories routinely used  
nested PCR assay for Dengue virus identification .This PCR assay 
comprises a two-step reaction  which involves an initial reverse 
transcription and amplification step that uses a universal Dengue primers 
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which mainly targets a region of the virus genome (C-prM) and is followed 
by a second amplification that is serotype specific. The resulting amplified 
product are separated by agarose gel electrophoresis, and  by  the  size  of  
the  bands Dengue serotypes  are  identified . 
Chien LJ et al.
96
 and Johnson BW et al
97
 proposed that the real-time 
RT-PCR assay is a one-step assay system using primer pairs and probes that 
are specific to each Dengue serotype. The reaction products are detected by 
a fluorescent probe enables without need for electrophoresis. Many real-
time RT-PCR assays have been developed either as „singleplex‟ or 
„multiplex‟ by their ability to detect one or four serotype from a single 
sample at a time respectively. . The advantage of multiplex assay is that all 
the four serotypes can be determined by a single reaction without the 
possibility for contamination during manipulation of the sample. 
Vaughn DW  et al
98
 reported that the fourplex real-time RT-PCR 
assays found to be  less sensitive than nested RT-PCR assay even though 
they are faster. This assay determines the viral load in a given sample, 
which is important in determining the severity of Dengue disease. Current 
PCR tests are 80–90% sensitive and >95% specific in detection of Dengue 
virus in acute phase sera
99
. 
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3.8.3.  Serological methods 
3.8.3.1. Haemagglutination Inhibition test (HI) 
This  is a simple, sensitive and reproducible test and has the advantage of 
using  locally prepared reagents. HI test requires paired sera that are 
obtained upon hospital admission (acute) and discharge
92
(convalescent). 
This test is based on the ability of Dengue virus antibodies to inhibit this 
agglutination
100
. A fourfold or greater rise in antibody titre is suggestive of a 
flavivirus infection and not diagnostic of Dengue infection. However, a 
single antibody titre>1/2560 is accepted as indicating secondary Dengue 
infection if supported by a clinical history suggestive of Dengue. Based on 
this principal, Immunochromatography is formed. These tests are mainly 
used in research purposes. 
Cordeiroet al
91
, 2007 proposed that quantification of HI antibodies (total: 
IgM and IgG)are done by a microtechnique  that serves to characterize the 
type of immune response according to WHO criteria . 
3.8.3.2.ELISA 
MAC ELISA 
MAC-ELISA is one among the classic serological test for Dengue. 
This assay utilizes all the four serotypes (DEN 1–4) of Dengue-specific 
antigens for the capture of anti DengueIgM-specific antibodies in serum 
samples. The antigens that are mostly used for this assay are derived from 
Dengue virus envelope protein. Specificity of these antigens and cross-
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reactivity with other circulating flaviviruses limits the usage of this test. 
These limitations are taken into consideration when working in regions 
where there is co-circulation of multiple flaviviruses. IgM detection is not 
useful for the determination of Dengue serotypes owing to cross-reactivity 
of the antibody, even during primary infections. 
              Guzman and Kouriet al,
101
 2004 reported that specific IgM 
antibodies are produced during both primary and secondary infection. Anti-
Dengue IgM can be detected, generally from  day  5 of the disease and may 
last for 60 to 90 days. Hence, the detection of IgM in any serum sample is 
indicative of recent or active infection within the last 2-3 months. The  
antibody production for DENV usually varies from those having primary 
and secondary infections. During the primary infection, IgM is usually 
detected from day 5 after the onset of illness, while  in secondary infection 
,IgM are detected in a titre lower than that of  the primary infection. 
Vorndam and Kuno et al,
82
 1997 observed that during a secondary infection, 
about 20% of patients do not have IgM at detectable levels .                                                                       
       According to the Pan American Health Organization (PAHO)
84 
guidelines ,IgM antibodies  are detectable by fifth day of illness in 80% of 
all Dengue cases, and by day 6–10 of illness in 93–99% of cases, and then  
may remain detectable for more than 90 days. MAC-ELISA has become a 
significant tool in the routine diagnosis of Dengue. This assay has a 
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sensitivity and specificity of 90% and 98% respectively  when used  ≥5 days 
after the onset of symptoms.  
            Vasquez S et al.
102
 2006 proposed that serum, blood on filter paper, 
and saliva (not urine)can be used for  IgM  antibody detection,if  the 
samples are taken within the appropriate time (≥5 days after the onset of 
fever) .The different commercial kits  are available which have variable 
sensitivity and specificity . 
             N Sathish et al
29
observed that MAC-ELISA  showed a high 
sensitivity (96%) as compared to  Rapid ICT (73%) and  the specificity was 
low (81%) when compared to Rapid (95%) . 
Hunsperger et al
103
evaluated six commercially available anti-Dengue 
IgM ELISA kits which showed mean sensitivities of ELISAs were 61.5%–
99.0%, and specificities were 79.9%–97.8%.  
          Similar study was conducted by Blackshell et al
104
on seven 
commercially available IgM ELISA and reported that the sensitivity and 
specificity was found to be ranging  from 85 to 89% and 88 to 100%, 
respectively . 
IgG  ELISA. 
The classic IgG ELISA are mainly used for the detection of a past 
Dengue infection.This assay uses the same antigens as that of the MAC-
ELISA. IgG ELISA is usually performed with multiple dilutions of the sera 
tested to determine an end-point dilution. This assay correlates with the 
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haemagglutination assay that was used in the past.Generally,IgG ELISA 
lacks specificity within the flavivirus sero-complex groups.  
Cardosaet al
105
 demonstrated that the IgG response to premembrane 
protein is specific to individual flaviviruses. No cross-reaction was observed 
when sera were tested from individuals infected with Dengue virus or 
Japanese encephalitis virus. IgG avidity ELISAs can be used to distinguish  
between a primary or secondary Dengue infection , and is more useful than 
the HI test for this purpose. 
Guzman and Kouri et al 
101
, 2004observed that IgG is detected at low 
levels from day 7 after the onset of illness in primary infection. On the 
contrary, during the secondary infection, IgG antibodies are detected at high 
levels even in the acute phase. 
Inoue et al
106 
revealed that the results of DEN IgG was highly 
correlated with that of the DEN HI test with a titer of 1:29,000 as the cut-off 
value for the diagnosis of Dengue secondary infection  90.9% sensitivity 
and 92.9% specificity . 
IgM/IgG ratio. 
The IgM/IgG ratio is also used to differentiate primary from 
secondary Dengue infection. A primary and secondary Dengue virus 
infection is considered when the capture IgM/IgG ratio is > 1.2 and < 1.2 
respectively. 
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           A recent study by Falconar et al.
88
 shows that the ratio differ variably 
depending on whether the patient has a serological classical or non- classical 
Dengue infection. The adjusted ratios of > 2.6 and less < 2.6 correctly 
classified 100% of serologically classical and 90% of serologically non-
classical Dengue infections. 
3.8.4. Viral antigen detection 
 ELISA, rapid immunochromatography and dot blot assays are 
directed against nonstructural protein (NS1) that detects Dengue infection 
upto day 6 after the onset of infection. Detection of NS1 antigens  do not 
distinguish the  virus serotypes.  
 Young et al.
107
, 2000 reported that NS1 protein exists in hexameric 
form and is highly conserved in all four DENV serotypes. This antigen was 
found circulating in the blood of patients from the day 1-9 after the onset of 
fever . As it is present in the serum during the acute phase of the infection, 
NS1 antigen is considered a marker used for early diagnosis of the disease, 
with a greater sensitivity in the first 5 days of disease. Detection of NS1 by 
ELISA is rapid and as sensitive as RT-PCR. 
 Based on the study by Hang et al.
108
, 2009,false-negative results may 
occur most probably due to the formation of immune complexes of NS1 
antigen with IgG, especially in secondary infections, where there is non- 
availablility of target antigen to the monoclonal antibody from ELISA. 
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McBride et al
109
2009 observed that NS1 antigen had a sensitivities of 97.5% 
and 59.1% for primary and secondary infections, respectively.  
Srivastava et al
110
compared  the evaluation of  NS1 Ag by ICT  with 
reference to NS1 capture ELISA in which the sensitivity, specificity, 
positive predictive value and negative predictive  value were 62.5% ,100%, 
100% and 88.15 % respectively. 
           A study by Kulkarni RD et al
111
 determined the association of 
platelet counts and Dengue serum markers (NS1, IgM and IgG) tested by 
rapid immunochromatography  test. 
3.8.5.Neutralisation test 
       During the primary infection, relatively monotypic neutralizing 
antibodies are detected whereas in the secondary infections, there is a 
production of high titre of neutralizing antibodies of two or more of the four  
DENV serotypes.  
Vorndam and Kuno et al,
82
1997  observed that  in combinations of 
sequential or  secondary infections, the highest titer for neutralizing 
antibodies present in the serum of convalescent patient is targeted against 
the virus that infected earlier .This phenomenon may hamper the 
interpretation of the serological test sometimes, known as “original 
antigenic sin”, 
A study by Roehring et al.
112
, 2008 shows that  the neutralizing test 
by plaque (PRNT)reduction  method is considered as “gold-standard” to 
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determine DENV serotype-specific immunity, though newer techniques are 
being currently developing to measure neutralizing antibodies . This PRNT 
technique is recommended by the WHO to assess the efficacy of Dengue 
vaccines under development . 
Morens et al 
113
, 1985 proposed that the neutralizing activity in serum 
is determined by their ability to reduce the largest number of viral plaques. 
The sample that shows reduction of 50% or more in plaque formation is 
considered as positive. PRNT is the most specific serological tool for the 
determination of Dengue antibodies.This test is mainly used to determine 
the infecting serotype in convalescent sera, measures the neutralizing 
antibodies titre in the serum of the infected individual and determines the 
protection level of the individual against the infecting virus. The assay is  
mainly based on the principle of virus interaction and antibody which results 
in virus inactivation in such  a way that it no longer infect and replicate in 
cell culture . Some variability are found in this assay which attributes to the 
differences in interpretation of the results. The cell lines and virus seeds 
used as well as the dilution of the sera accounts for these differences. 
The microneutralization assay is based on the same principle as that 
of PRNT. For determining the end-point dilution, this assay uses a 
colorimetric measurement of virus-induced lysis of cells instead of counting 
the number of plaques per well as in PRNT. This assay utilizes small 
amounts of reagents and is also suitable for testing large numbers of 
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samples. During secondary infections, this  assay shows a poor correlation 
with PRNT results which limits its use.  
3.8.6.Immunochromatograpy 
Immunochromatographic tests are used for the detection of Dengue 
virus NS1 antigen, IgM, IgG, and IgA antibodies. These RDTs are 
commercially available nowadays and have found wide application because 
of their ease of use and rapidity of results. These RDTs are presented in the 
form of a lateral flow cassette which allow the sample to flow in a 
horizontal plane or in a vertical plane where the sample in a tube is drawn 
by capillary action. The Dengue RDTs have the advantage that they are less 
time consuming (15–20 minutes),does not require any special equipment or 
training. 
 Stuart D Blacksell et al
104
  compared  the   accuracy of 8 Commercial 
Rapid Immunochromatographic Assays for the Diagnosis of Acute Dengue 
Virus Infection and found  that  the    assay  sensitivities  were low, ranging 
from 6.4% to 65.3%and specificities ranged from 69.1% to 100% . 
          Similar study  by V. Tricou et al
114
 showed sensitivity  and specificity 
of 75.5% and 100% respectively.A multicentre evaluation of Dengue IgM 
antibody RDTs  by  Hungsper et al,  sponsored by WHO showed  sensitivity  
ranging  from 21% to 99% and specificity ranging from 77% to 98% when 
compared with reference ELISAs 
103
.  
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Saini et al
18
showed that 198 cases were positive for NS1 antigen and 40 
cases were considered as primary infection (84.6%)which showed the 
presence of Dengue specific IgM antibodies /with or without NS1 Ag . 43 
cases (15.3 %) were categorized as secondary infection  which is indicated 
by the presence of Dengue specific IgG antibodies with or without any other 
parameter by Immunochromatography .Sekaran et al
115
reported the 
sensitivity and specificity in diagnosing acute Dengue infection in the SD 
Duo NS1/IgM were 88.65% and 98.75%, respectively. 
Hunsperger et al
103
evaluated four commercially available RDT kits  
for detection of IgM antibodies that showed Mean sensitivities  and 
specificities to be 20.5%–97.7%, and 76.6%–90.6% respectively. 
 Hasan et al 
116
in  his  study revealed  that  the sensitivity / specificity 
of Dengue IgG, IgM, IgA and rapid antigen by ICT were compared with 
ELISA IgM (gold standard) and these were 33.3/100%, 
16.67/88.89%,50.0/77.78%, 23.3/88.8% respectively. 
3.8.7.Comparison of diagnostic methods 
          Lam et al
117
 evaluated rapid immunochromatographictest and ELISA 
for the detection of IgM and IgG antibodies produced during Dengue 
infection. Both assays showed excellent sensitivity(100%) diagnosing 
primary and secondary Dengue infection  and specificity in both assays was 
89% . 
43 
 
  A study by Gargi ghosh et al
21
revealed that the, sensitivity and 
specificity of NS1 ICT were found to be 91.2% and 78.4%, while that of 
NS1 ELISA were found to be 75% and 88% with RT-PCR as standard 
reference. 
          In a study by Datta et al
118
,  the performance of NS1 antigen (Ag) 
assay was evaluated in comparison to MAC-ELISA and  to determine their 
detection rate when performed together in a single sample.  Out of 600 early 
convalescent sera were screened by both the assays, the sensitivity of NS1 
and MAC-ELISA were 23.3% and 39.1% respectively. The detection rate 
increased to 53.3% when both the assays were used together on a single 
sample. NS1 Ag assay holds promise in early diagnosis of Dengue infection. 
When used in combination with MAC-ELISA on a single sample it 
significantly improves the diagnostic algorithm without the requirement of 
paired sera.  
     Lanciotti et al
95
compared  and analyzed the efficacy of  RT-PCR 
assay and virus isolation for the identification and typing of Dengue viruses 
from human serum.The  RT-PCR assay demonstrates sensitivities of 94% 
with Dengue type 1 virus, 93% with Dengue type 2 virus, and 100% with 
Dengue type 3 and 4 viruses, compared with virus isolation. 
 Chungue et al
119 
studied on comparison of IgG-ELISA to the 
haemagglutination inhibition test (HI). and found that the sensitivity, and 
specificity between the 2 techniques were good. The coefficients of 
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correlation between IgG-ELISA and HI results, using Dengue 1-4 antigens, 
were highly significant . 
3.9.TREATMENT 
The management of Dengue virus infection is essentially supportive 
and symptomatic. No specific treatment is available.  
3.9.1.Management of Dengue fever 
Fever is treated with anti-pyretics (paracetamol). Nonsteroidal anti- 
inflammatory drugs such as ibuprofen or aspirin  should be avoided. Tepid 
sponging is helpful.  Antiemetic such as domperidone and a proton pump 
inhibitor (pantoprazole) can be used. Increased oral fluids are adviced  
during  the  early  phase  of  the  disease; intravenous fluids are  
administered  in presence of severe vomiting or dehydration. 
3.9.2.Management  of   DHF 
Cautious administration of IV fluids are adviced to avoid respiratory 
distress secondary to massive pleural effusions/ ascites or pulmonary 
edema. Intravenous fluid therapy should be stopped when the packed cell 
volume(PCV) falls to 40% generally  heralding  the  convalescent  phase. 
3.9.3.Management  of  DSS 
Significant hemorrhagic manifestations requires platelet transfusions. 
Electrolyte abnormalities, metabolic acidosis and hypoglycemia should be 
corrected. Laboratory indicators should be looked for monitoring 
disseminated intravascular coagulation (DIC).Depending upon clinical  and  
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laboratory parameters of  the  individual ,Fresh frozen plasma, platelet 
concentrates, or cryoprecipitate are  administered  . 
3.10.PREVENTION OF  DENGUE 
 
There is no availability of vaccine and there is no specific 
medications to treat a Dengue infection. This makes prevention the most 
important step. Prevention is by avoiding mosquito bites if living in or travel 
to an endemic area.The best way is to reduce mosquito beeding places like 
artificial containers that hold water in and around the home. Outdoors, clean 
water containers like  animal watering containers, flower planter dishes or 
cover water storage  barrels,standing  water  indoors  such as flower  vases 
and  should  be  cleaned  at  least  once  a  week. The adult mosquitoes bite 
inside as well as around homes, during the day and at night when the lights 
are on. To protect from bites repellents are used while indoors or out. 
Windows and door screens are to be secured and be without holes. If 
someone in the house is ill with Dengue, extra precautions are taken to 
prevent mosquitoes from biting the patient and to bite other household 
contacts .Mosquito  nets  and  repellents  are adviced to eliminate 
mosquitoes found indoors.
 
3.11 VACCINE         
There is no Dengue vaccine available against  Dengue  at present. 
Research is in progress to develop a  safe and  effective tetravalent Dengue 
vaccine. Many Dengue vaccines, e.g.live attenuated, recombinant vaccines 
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and inactivated whole virus  are  in  developmental  process  and  some were  
in phase 2 field trials. In   the  absence  of   Dengue  vaccine , prevention  
and  containment of  Dengue outbreak  requires  an  effective  long-term  
vector  control with community participation  and  aggressive  
epidemiological  surveillance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                  
47 
 
4.MATERIALS AND METHODS 
 
         The present study was conducted at the Department of Microbiology , 
Tirunelveli Medical College , Tirunelveli from  May 2013 to March 2014 to 
evaluate the efficiency of rapid immunochromatographic test(ICT) in 
Dengue NS1 antigen, IgM  and IgG antibody detection and also to compare 
its performance against NS1 antigen, IgM and IgG antibodies detection by 
Enzyme Linked Immunosorbent Assay (ELISA) respectively. 
4.1 Study group 
Atotal of 100 serum samples were collected from clinically suspected  
Dengue cases in adults. 
4.2 Inclusion criteria 
 Serum samples of patients with acute onset of fever of >4 days, 
clinically suspicious of Dengue virus infection 
 Adults requiring hospitalization 
4.3 Exclusion criteria:  
 Patients with any other proven febrile illnesses like Malaria, Typhoid 
etc. are excluded. 
 Children <12 years of age. 
4.4 Ethical clearance 
Ethical clearance was obtained from the college ethical committee 
before the commencement of the study. 
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4.5 Consent 
Informed consent was obtained from reliable informants of patients 
who participated in the study. 
4.6 Questionniare 
Symptoms regarding the onset of fever, duration, presence of other 
clinical features like chills, rigor, vomiting,retro-orbital pain, myalgia and 
other features of haemorrhagic manifestations,leucopenia,thrombocytopenia 
and rising haematocrit were recorded in the questionnaire. 
History of previous hospitalization, mosquito bite, domestic water 
storage and stagnant water around the living area was also included in the 
questionnaire. 
4.7Study sample 
A total of 100 non-duplicate serum samples were collected from the 
study group. Around 5 ml of blood sample was collected from suspected 
cases in the acute phase of the illness.  Serum was separated and  collected  
in  serum  vial .The specimen was properly labeled with serial number , 
name of the patient and date of collection. 
4.8 Storage of sample 
Sample were immediately  tested  for  Dengue NS1 antigen , IgM and 
IgG antibodies by  rapid  immunochromatographic  method  and  then  
stored  for  ELISA at  -80 
o 
C. 
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4.9 METHODS 
All 100 samples were tested for Dengue parameters (NS1 antigen, 
IgM  andIgG antibodies)  by  both  rapid  immunochromatography  and  
ELISA. 
4.9.1 Immunochromatography 
All  the  100  samples  were  tested  by  rapid  immune 
chromatography  card  test (SD BIOLINE  DENGUE NS1 +Ab COMBO). 
Test principle 
In general, ICT is a lateral flow assay  that contains a 
chromatographic pad with three zones - sample pad , conjugate pad  and  
capture line.Colloid  gold is impregnated in the conjugate pad.  When the 
specimen is  applied to the sample pad, it flows laterally by capillary action. 
On  reaching  the  conjugate  pad  it forms  antigen-antibody  complex  by  
binding to  the  antibody conjugate in the pad .This complex  then flows 
laterally to reach the capture line where it is captured by second antibody. 
The presence of coloured line indicates a positive  result. 
This rapid test cassette contains two windows, one for  detection of 
NS1 antigen and IgM/IgG antibody  each. The Dengue NS1 window 
contains two pre coated lines, „„T” as NS1 antigen test line and „„C” as 
control line. Dengue IgG/IgM rapid test is designed to simultaneously detect 
and differentiate IgG and IgM antibodies to Dengue virus in the sample. 
This device detect all four Dengue serotypes by using a mixture of 
50 
 
recombinant Dengue envelope proteins. Dengue IgG/IgM test device 
contains three precoated lines, „„G” as Dengue IgG test line, „„M” as 
Dengue IgM test line and „„C” as control line on the surface of the device. 
Materials provided 
The rapid immunochromatographic test kit contains the following 
items to perform the assay 
 Dengue NS1 antigen  and Dengue IgG/IgM combo device 
 Assay diluents for Dengue IgG/IgM test 
 10μl capillary pipette for Dengue IgG/IgM test 
 Disposal dropper for Dengue NS1 antigen   
Active ingredients of main components 
Dengue NS1 antigen test device 
 1st test strip included: Gold conjugates (as main component):mouse 
monoclonal anti-Dengue NS1-gold colloid 
 Test line (as main component):  Mouse monoclonal anti-Dengue NS1 
 Control line(as main component): Goat anti-mouse IgG. 
Dengue IgG/IgM test device 
 1st test strip included: Gold conjugates (as main component): 
Recombinant Dengue virus envelope protein gold colloid 
 Test line „„G”( as main component): Mouse monoclonal anti-human 
IgG 
51 
 
 Test line „„M” (as main component):  Mouse monoclonal anti-human 
IgM 
 Control line  (as main component):  Rabbit anti-Dengue IgG 
 Assay buffer included: 100 Mm Phosphate buffer  and  Sodium azide. 
Kit storage  
The Dengue duo test kit was stored at 1~ 30 
0  
C. 
Procedure of the test 
Dengue NS1 antigen test device 
 100μl  or 3 drops of the specimen were added to the sample well(S) 
with a help of a disposable dropper. 
Dengue IgG/IgM test device 
 With  a capillary pipette, 10 μl  of specimen  was added to the  square 
sample well marked as ״S״. 
 4 drops of assay  diluent  was added to the  round shaped assay 
diluent well  
Interpretation of the test 
Dengue NS1 antigen test device 
Negative  result : The presence of each one colour line within the result 
window indicates a negative result. 
Positive result: The presence of two coloured lines („„T”  band and 
„„C‟‟band) within the result window  no matte which line appears 
first,indicates a positive result. 
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Invalid  result :  If the colour is not visible  within the result  window after 
performing the test,the result  was considered invalid. 
Dengue IgG/IgM test device 
Negative  result : The control line is only visible on the test device. 
IgMPositive: The control line(C) and IgM line (M) are visible on the test 
device. This is positive for IgM antibodies to Dengue virus. This is 
indicative of a primary Dengue infection. 
IgGPositive : The control line and IgG line (G) are visible on the test 
device. This is positive for IgG antibodies. This is indicative of  secondary 
or past Dengue infection. 
IgG and IgMPositive : The control line,IgM(M),IgG(G) are visible on the 
test device. This is positive for both IgM and IgG antibodies. This is 
indicative of late primary or early secondary Dengue infection. 
Invalid  : The control line fails to appear within  the result window after 
performing  the  test,  the  result  is  considered  invalid. 
4.9.2. NS1 antigen ELISA 
All 100 samples were tested for detection of NS1 antigen by 
ELISA(PANBIO DENGUE EARLY ELISA KIT) 
Principle of the test 
Serum Dengue NS1 antigen, when present, binds to anti-
NS1antibodies attached to polysterene surface of the microwells. Residual 
serum is removed by washing. And HRP conjugated anti-NS1 MAb is 
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added. After incubation, the microwells are washed and a colourless 
substrate system, tetramethyl benzidine/hydrogen peroxide (TMB 
chromogen) is added. The substrate is hydrolysed by the enzyme and the 
TMB changes to a blue colour. After stopping the reaction with acid, the 
TMB   turns yellow. Colour development is indicative of the presence of 
Dengue NS1 antigen in test sample. 
Materials provided  
 Anti-NS1 Antibody Coated Microwells(12×8 wells) 
 HRP Conjugated Anti-NS1 MAb – 15 ml,one bottle. Horseradish –
peroxidase conjugated Anti-NS1 monoclonal antibody with 
preservative(0.1 % Proclin
TM
).  
 Wash buffer (20×) – one bottle, 60 ml of 20 × concentrate of 
phosphate buffered saline (p
H
 7.2 – 7.6) with Tween 20 and  
preservative (0.1 % Proclin
TM
).   
 Sample diluent – one bottle 22 ml. Tris   buffered saline (pH 7.2 – 7.6) 
with preservative(0.1 % Proclin
TM
).  
 TMB Chromogen (TMB) – One bottle ,15 ml. A mixture of 3,3‟,5,5‟-
tetramethylbenzidine and hydrogen peroxide in citric acid citrate 
buffer (p
H 
 3.5 – 3.8). 
 Positive control – one purple –capped vial, 1.2ml recombinant antigen 
(contains 0.1 % Proclin
TM
 and 0.005% gentamycin sulphate). 
 Calibrator  -  two orange – capped vials , 1.5ml  recombinant antigen             
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(contains 0.1 % Proclin
TM
 and 0.005% gentamycin sulphate). 
 Negative  control -  one white –capped vial, 1.2 ml human serum 
(contains  0.1% sodium azide and 0.005 % gentamycin sulphate) 
 Stop  solution – one red –capped bottle, 15ml.1M Phosphoric acid.  
Test  procedure 
 All reagents was equilibrated to room temperature (20-250C)before 
commencing the assay. 
 Control and Sample predilution 
1) Required number of micro wells were removed from the foil and 
was inserted into the strip holder. Five microwell are required for 
Positive control(P),Negative control (N),Calibrator (CAL)in 
triplicate. 
2) 75 μl of Sample diluent was added to 75 μl of Positive 
control,Negativecontrol,Calibrator and serum samples. Mixed 
well. The final dilution of the sample is 1 in 2. 
ELISA  Procedure 
 100 μl of diluted test samples and controls were pipetted into their 
respective microwells. 
 The plate was covered and incubated for 1 hour at 370 C. 
 Washed six times wth diluted wash buffer 
 100 μl  of HRP conjugated Anti-NS1 MAb was pipetted into each 
well. 
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 The plate was covered and incubated for 1 hour at 370 C.  
 Washed six times wth diluted wash buffer. 
 100 μl  of TMB was pipette into each well . 
 Incubated at room temperature (20-250 C) for 10 minutes, timing from  
the first addition.there was development of blue colour. 
 100 μl  of Stop solution was pipette to all wells and mixed well. The 
blue colour  changed to yellow. 
 The absorbance of each well  was read within 30 m wavelength of 
450 nm with a  reference filter of 600-650nm. 
Calculations 
 The calibration factor is batch specific and the calibration factor value 
was obtained before commencing calculations.   
 The average absorbance of the calibrator triplicates was calculated 
and multiplied by the calibration factor. This gives the Cut-off Value. 
 An Index value was calculated by dividing the sample absorbance by 
the Cut-off value. 
 Alternatively ,Panbio units can be calculated by multiplying the Index 
value by 10. 
 Index  value  =  Sample Absorbance / Cut – off  value 
 Panbio Units  = Index value × 10 
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Interpretation of results 
Diagnosis of Dengue infection :  This early ELISA kit assesses the 
presence of Dengue NS1 antigen in the patient‟s serum. A positive result (> 
11 Panbio units) is indicative of either an active primary or secondary 
Dengue infection.  It does not differentiate between primary and secondary 
infection. 
               INDEX        PANBIO UNITS               RESULT 
< 0.9 < 9                Negative 
  0.9  – 1.1    9 – 11                Equivocal 
>1.1 > 11                Positive 
 
Negative  result :  No detectable Dengue NS1 antigen.  This result does not 
rule out Dengue infection. If this sample is negative and Dengue infection is 
still suspected, a follow up sample should be taken and tested,using 
serology, no later than 14 days l after the initial sample was taken. 
Equivocal  result : Equivocal samples should be repeated. Samples that 
remain equivocal after  repeat testing should be repeated by an alternative 
method or another sample should be collected. 
Positive  result  : Presence of detectable Dengue NS1 antigen. Dengue 
serology assays should be performed on follow – up samples to confirm 
Dengue infection. 
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4.9.3. IgG  CAPTURE  ELISA 
All 100 samples were tested for detection of IgG antibodies by 
CAPTURE ELISA(SD  DENGUE  IgG  CAPTURE  ELISA  KIT). 
Principle of the test 
 IgG Capture ELISA is an Enzyme Linked Immunosorbent Assay for 
the qualitative detection of IgG antibodies against Dengue virus antigen in 
human serum. This kit contains a microplate, which is pre-coated with 
mouse monoclonal anti-human IgG antibodies on well. During first 
incubation with withmicroplate,anti – Dengue IgG antibody in patient serum 
is bound to mouse monoclonal anti-human IgG antibodies on well,and then 
is bound to mixture of Dengue antigen and mouse monoclonal anti- Dengue 
HRP Conjugate. Following this incubation,all unbound materials are 
removed by aspiration and washing. The residual enzyme activity found in 
the wells will thus be directly proportional to the mouse monoclonal anti-
Dengue IgG antibody concentration in patient serum and evidenced by 
incubating the solid –phase with a substrate solution (Working TMB). 
Colorimetric reading will be performed by using a spectrophotometer at 
450nm. 
Materials provided 
 Coated microplate : 96 wells (12×8 wells),coated anti-human IgG 
antibodies. 
 Dengue antigen : Dengue 1~4 antigens pool. 
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 Sample diluents :Tris buffer saline with preservative NaN3(0.05%) 
 Mouse monoclonal anti-Dengue IgGonjugate(2×) : Anti-Dengue 
Antibodies conjugated to horseradish peroxidase(HRP) with 
preservative Thiomersal (0.01 %) 
 Conjugate diluents : Phosphate buffered saline,BSA  and stabilizers 
with preservative Thiomersal(0.01%). 
 Positive control : Inactive Anti-Dengue IgG/IgM antibody positive 
human serum with preservative  Proclin 300(0.01%) 
 Negative control : Anti-Dengue IgG/IgM antibody negative human 
serum with preservative  Proclin 300(0.01%). 
 Working TMB : Hydrogen peroxidase Tetramethylbenzidine (TMB) 
 Washing solution (20 x) : PBS –Tween 20 
 Stopping solution : 1.6 N sulfuric acid. 
 Adhesive plate sealer. 
Active ingredients of materials and reagent provided 
 Coated microplate  :  includes mouse monoclonal anti-human IgG 
antibodies(as a main component) 
 Anti-Dengue IgG HRP conjugate (2x) : consists of mouse 
monoclonal anti-Dengue IgG antibodies conjugated solution to 
horseradish peroxidase (as a main component) with Thiomersal. 
 Conjugate diluent : consists of phosphate buffered saline,BSA and 
Thiomersal. 
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 Sample diluent ; includes Tris,NaCl,NaN3 
 Positive control : consists of  inactive anti-Dengue IgG/IgM antibody 
positive human serum with  proclin 300. 
 Negative control :  includes anti-Dengue IgG/IgM antibody negative 
human serum with  proclin 300. 
 Working TMB : contain Hydrogen peroxidase with 
tetramethylbenzidine(TMB) 
 Washing  solution (20X) : contains phosphate buffer solution,Tween 
20 and Thiomersal. 
 Stopping solution : contains 1.6N sulfuric acid. 
Kit storage 
IgG capture ELISA  assay kit was stored at 2~8
0 
C. 
Test procedure 
Sample  predilution 
The test strip wells and other reagents was prepared and brought to 
room temperature. 
With the suitable test tubes 3 negative controls, 2 positive controls 
and serum sample  were  diluted  with  sample  diluent  in  the  ratio  of 1 in 
100  and  mixed well. 
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ELISA  procedure 
Dengue  antigen 
A bottle of Dengue antigen powder was diluted using 1.5 ml of the 
Conjugate diluent. 
Anti-Dengue HRP Conjugate  1 : 1 was diluted with diluted Dengue 
antigen and gently  mixed  and  left  at  room  temperature  for  60  minutes. 
Assay  plate 
 100 μl   of diluted controls and serum sample were added to their 
respective wells of the microplate. 
 The  microplate was then covered with adhesive plate sealer and 
incubated at 37
0
C  for 60 minutes. 
 The  wells  were washed 5 times with diluted  washing solution using 
an automatic washer. 
 The diluted Anti-Dengue HRP conjugate solution was mixed well  
before transfer and  100 μl  of the diluted Anti – Dengue  HRP 
conjugate solution into the appropriate wells of microplate.  
 The  microplate was then covered with adhesive plate sealer and 
incubated at 37
0
C  for 60 minutes.  
 The  wells  were washed 5 times with diluted  washing solution using 
an automatic washer. 
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 100 μl  of working  TMB was pipette into each value and incubated 
for 10 minutes at room temperature. Blue colour developed in the 
wells.  
 100 μl  of stopping solution was pipette into each wells and mixed 
well and the blue colour changed to yellow. 
 The absorbance of each well was read within 30 minutes at a 
wavelength of 450nm with a reference filter of 620nm. 
Interpretation of the test 
Calculations  
The mean absorbance of the negative controls was calculated ,then 
the cut-off value was calculated by adding 0.300. 
Based on the criteria of the test, the samples are classed as follows: 
Test results : 
1) absorbance of sample  <  cut-off  =  anti-Dengue IgG negative 
2) absorbance of sample  >  cut-off  = anti-Dengue IgG  positive 
Negative result : no evidence of a past Dengue infection. If a recent 
Dengue infection is suspected,this can be confirmed by testing a further 
specimen 7 ~ 14 days after. 
Positive result : presence of detectable anti-Dengue IgG antibodies 
indicates evidence of past or recent infection. 
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4.9.4. DENGUE IgM CAPTURE ELISA 
All 100 samples were tested for detection of IgM antibodies by 
CAPTURE ELISA (PANBIO  DENGUE IgM  CAPTURE  ELISA  KIT). 
Principle of the test 
Serum antibodies of the IgMclass,whenpresent,combine with anti-
human IgM antibodies attached to polysterene surface of the microwell test 
strips. A concentrated pool of of Dengue 1-4 antigens is diluted to the 
correct working volume with antigen diluents. The antigens are produced 
using aninsect cell expression system and immunopurified utilizing a 
specific monoclonal antibody. An equal volume of HRP conjugated 
Monoclonal Antibody (MAb) is added to the diluted antigen,which allows 
formation of antigen –MAbcomplexes.Residual serum is removed from the 
assay plate by washing,and complexed antigen-MAb is addaed to the assay 
plate. After  incubation,the microwells are washed and a colourless substrate 
system,tetramethylbenzidine / hydrogen peroxide (TMB Chromogen)is 
added. The substrate is hydrolyzed by the enzyme and the chromogen 
changes to a blue colour. After stopping the reaction with the acid,the TMB  
becomes yellow.  Colour development is indicative of the presence of anti-
Dengue IgM antibodies in the test sample. 
Materials  provided 
Anti-human   IgM  coatedmicrowells (12x8 wells). 
Dengue 1-4 antigens(recombinant)- 150μl vial 
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Wash buffer(20x) -60 ml of 20x concentrate of phpsphate buffered 
saline (p
H
 7.2-7.6) with Tween 20 and preservative(0.1% proclin) 
Sample diluents – 50 ml(2 bottles): contains  Tris  buffered  saline (pH 
7.2-7.6) with  preservative(0.1% proclin) and additives. 
Antigen diluents- 50 ml:includes Phosphate buffer containing 
preservatives(0.1% proclin and 0.005% gentamycin) 
HRP Conjugated Monoclonal Antibody Tracer – 7ml. Includes  
Horseradish peroxidase conjugated monoclonal antibody tracer with 
preservative (0.1% proclin)and protein stabilizers . 
TMB Chromogen(TMB) – 15 ml . A mixture of 3,3‟,5,5‟-
tetramethylbenzidine and hydrogen peroxide in a citric-acid citrate buffer 
(p
H 
 3.5 – 3.8) 
Positive control  - 200 μl human serum (contains 0.1% sodium azide 
and 0.005% gentamycin sulphate)human serum  
Calibrator – 400 μl  human serum (contains 0.1% sodium azide and 
0.005% gentamycin sulphate) 
Negative  control -  200 μl human serum (contains 0.1% sodium azide 
and 0.005% gentamycin sulphate) 
Stop solution  - 15ml,contains 1M Phosphoric acid. 
Test  procedure 
 All reagents was equilibrated to room temperature (20-250C) before 
commencing the assay. 
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 Control and Sample predilution 
1) Required number of micro wells were removed from the foil and 
was inserted into the strip holder. Five microwell are required for 
Positive control(P),Negative control (N),Calibrator (CAL)in 
triplicate. 
2) 90 μl of Sample diluent was added to 10 μl of Positive control, 
Negative control, Calibrator and serum samples. Mixed well. The 
final dilution of the sample is 1 in 10. 
ELISA  Procedure 
Antigen  
Antigen was diluted 1/250 using antigen diluent. 10 μl of antigen was 
diluted into 2.5ml of antigen diluent which was sufficient for upto five 
strips. A volume of 0.5ml of diluted antigen was required per strip. 
Required volume of diluted antigen was mixed with an equal volume 
of MAb Tracer in a clean vial and gentlt mixed the antigen-MAb Tracer 
solution and left at room temperature. 
Assay plate 
Within  10 minutes after the MAb Tracer was mixed  with diluted antigen, 
 100 μl of diluted test samples and controls were pipetted into their 
respective microwells. 
 The plate was covered and incubated for 1 hour at 370 C. 
 Washed six times with diluted wash buffer 
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 100 μl  of antigen- MAb complexes from the antigen vial was 
pipetted into each well. 
 The plate was covered and incubated for 1 hour at 370 C.  
 Washed six times with diluted wash buffer. 
 100 μl  of TMB was pipette into each well . 
 Incubated at room temperature (20-250 C) for 10 minutes , timing from  
the first addition.there was development of blue colour. 
 100 μl  of Stop solution was pipette to all wells and mixed well. The 
blue colour  changed to yellow. 
 The absorbance of each well  was read within 30 m wavelength of 
450 nm with a  reference filter of 600-650nm. 
Calculations 
 The calibration factor is batch specific and the calibration factor value 
was obtained before commencing calculations.   
 The average absorbance of the calibrator triplicates was calculated 
and multiplied by the calibration factor. This gives the Cut-off Value. 
 An Index value was calculated by dividing the sample absorbance by 
the Cut-off value. 
 Alternatively ,Panbio units can be calculated by multiplying the Index 
value by 10. 
 Index  value  =  Sample Absorbance / Cut – off  value 
 Panbio Units  = Index value × 10 
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Interpretation of results 
Diagnosis of Dengue infection :  This early ELISA kit assesses the 
presence of Dengue NS1 antigen in the patient‟s serum. A positive result (> 
11 Panbio units) is indicative of either an active primary or secondary 
Dengue infection.   
INDEX PANBIO UNITS RESULT 
< 0.9 < 9 Negative 
0.9  – 1.1 9 – 11 Equivocal 
>1.1 > 11 Positive 
 
Negative  result :  No detectable Dengue IgM antibody.  The result does not 
rule out Dengue infection. An additional sample should be tested in 7-14 
days if early  infection is suspected. Other  Dengue assays should be 
performed to rule out  acute  infection. 
Equivocal  result : Equivocal samples should be repeated. Samples that 
remain equivocal after  repeat testing should be repeated by an alternative 
method or another sample should be collected. 
Positive  result  : Presence of detectable Dengue IgM antibody. Dengue 
serology assays should be performed  to confirm Dengue infection. 
 
 
                                                 
 
 Figure  1 : Dengue  Rapid  ICT Kit 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  2: Card  Test  Positive  For  All  The Three  
Parameters(NS1,IgM , IgG) 
 
 
 
 
Figure   3 :  Card  Test  Negative   For  Three  Parameters 
 
 
 
 
 
 
 
 
Figure  4 :  Card  Test  Positive  For  NS1  Antigen. 
 
 
 
 
 
 
Figure  5 :  Card  Test  Positive  For  IgM  And  IgG  Antibodies. 
 
 
 
 
 
Figure  6 :  Dengue  Elisa  Kit 
 
 
 
 
Figure  7  : Microtire  Plate 
 
 
 
 
 
 
Figure   8  : Elisa   Reader 
 
 
 
Figure   9  : Elisa   Washer 
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5. RESULTS 
 
5.1 The Study Group 
A total of 100 adults aged above 12 years with complaints of fever 
more  than 4 days with thrombocytopenia ( i.e.suspected  Dengue  cases) 
were analyzed. This study  was  conducted  at  the  Department of 
Microbiology , Tirunelveli  Medical College  Hospital ,Tirunelveli  over  a  
period  of  one  year  from  May  2013  to  March  2014.  
5.2 Statistical Analysis 
All  the  results  obtained  were  analysed  statistically  for  their  
completeness ,  consistency  and  accuracy  by  the  parameters  like  mean  
and  percentages. Kappa  value  was  calculated  to  measure  the  degree  of 
agreement  between  two diagnostic  methods - Rapid  ICT  and  ELISA . 
The above  statistical  procedures  were  performed  by IBM SPSS Statistics 
20. Chi-square test  and Fisher  Exact  test were  used  in  calculating  the  P-
value. The  P-Values  of  less  than  0.05 were  considered  as  statistically  
significant (P<0.05). 
5.3 Result  Analysis 
The  selected  100  study  subjects  were  analyzed  based  on  age  
and  sex, The  results  of  the  analysis  are  tabulated  in Table 1. 
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Table 1.Age and sex wise distribution in study group 
Age (in years) Male Female Total 
No. % No. % No. % 
11-20` 
 
21-30 
 
31-40 
 
41-50 
 
51-60 
 
61-70 
24 
 
16 
 
12 
 
4 
 
1 
 
2 
40.6% 
 
27.1% 
 
20.3% 
 
6.8% 
 
1.7% 
 
3.4% 
 
18 
 
11 
 
6 
 
4 
 
2 
 
0 
43.9% 
 
26.8% 
 
14.6% 
 
9.8% 
 
4.9% 
 
0 
 
42 
 
27 
 
18 
 
8 
 
3 
 
2 
42% 
 
27% 
 
18% 
 
8% 
 
3% 
 
2% 
Total 59 59% 41 41% 100 100% 
 
Of the 100 patients, 59(59%) were  males and 41(41%)  were females. A  
total of 42(42%) cases were in  the  age  group of 11-20 of which 24(40.6%) 
cases were males and 18(43.9%) cases were from females. 27(27%) cases    
belong to  the age  group  of  21-30 years ,of  which 16(27.1%) cases belong 
to males 11(26.8%) cases belongs  to female.Out of 18(18%)cases  in the 
age group of 31-40 years,12(20.3%) and 6(14.6%) were from  males and 
females respectively.A total of 8(8%) belongs to the  age group of 41-50 
years,of which 4(6.8%) and 4(9.8%) were from males and females 
respectively.3(3%)case were in the age group of 51-60  years,among which 
1(1.7%) and 2(4.9%) were males and females respectively.Only 2(2%) 
cases belongs to 61-69 years,of which 2(3.4%) were males and no females 
belongs to this age group.(Fig  10 ) 
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Table 2.Distribution of associated clinical features in study group. 
Clinical features No. of patients 
(n =100) 
Percentage 
Vomiting 
Headache 
Myalgia 
Bleeding manifestations 
Abdominal pain 
55 
55 
73 
19 
11 
55% 
55% 
73% 
19% 
11% 
 
The  above table  shows that  among  the  100  cases  studied,  55% of  
cases were associated with  vomiting , 55%  had  headache , 73 %  had  
myalgia, 19%  had  bleeding  manifestations  and 11%  had  abdominal 
pain.(Fig  11) 
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Figure  10 .Age and sex wise distribution in study group. 
 
 
Figure  11. Distribution of associated clinical features in study group. 
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Table  3. Laboratory  findings  among  the  study  group 
Test No.of patients 
(n=100) 
Percentage 
 Thrombocytopenia  
Elevated Haematocrit 
Leucopenia 
Elevated liver enzymes 
100 
37 
31 
11 
100% 
37% 
31% 
11% 
 
The  table  above (figure ) shows that  out  of  100  cases  studied, 
haematocrit (Hct) was  found  to  be  elevated  in  37%  and  31%  presented  
with  leucopenia and  11%  had  elevated liver enzymes .  
Thrombocytopenia  was present  in all the  study  group.(Fig 12) 
Table  4. Ultrasonography  findings  among  the  study  group. 
USG  findings No. of patients 
(n=100) 
Percentage 
Ascites 
Pleural effusion 
GB wall edema 
 
13 
9 
9 
 
13% 
9% 
9% 
 
 
The   ultrsonography  findings  from the above table 4(fig 13 ) shows that  
among  the  100  patients  studied,  13%  had ascites, 9% had pleural 
effusion ,and  9% presented  with   GB  wall edema . 
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Figure  12 . Haematological  findings  among  the  study  group 
 
 
 
Figure  13. Ultrasonography  findings  among  the  study  group. 
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Table 5.Detection  of  Dengue  cases  by rapid ICT and ELISA (by any 
one of the parameters) 
Test Sample tested         Positive       Negative 
Cases % Cases % 
ELISA 
 
ICT 
        100 
 
         100 
59 
 
38 
59% 
 
38% 
41 
 
62 
41% 
 
62% 
 
            All the 100 samples were tested by both  rapid  ICT and  ELISA  for 
Dengue parameters(NS1 antigen, IgM and IgG antibodies). Out of this 
,ELISA  was positive for 59% of samples while 38% were positive by  ICT 
as shown in table 5(figure 14 ). 
Figure  14 .Detection of Dengue cases by any one of the parameters. 
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Table  6. Comparison  of  ICT  and  ELISA. 
 
            ICT 
ELISA 
Positive Negative 
          Positive 
         Negative 
37 
22 
1 
40 
            Total 59 41 
 
            Detection  of  Dengue  positive  cases  by  rapid  
immunochromatographic  card test  was  evaluated  for  its  sensitivity  and  
specificity  against   ELISA  as  reference  test   for  NS1  antigen,IgM and  
IgG antibody   detection. 
Sensitivity   = 62.7% 
Specificity   =97.6% 
Positive predictive value   =97.4%  
Negative predictive value  =64.5%.  
           From   the  above  table , sensitivity  of  rapid  ICT  was  62.7%  
when evaluated  against  ELISA , a  reference  test. Specificity of ICT was 
97.6% compared to ELISA and positive and negative predictive value were 
97.4%  and  64.5%  respectively. 
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Table  7: Detection  of  Dengue  parameters   by  ICT  and  ELISA 
DENGUE 
PARAMETERS 
(alone  or in 
combination) 
 
 
NO. OF POSITIVES 
ICT ELISA 
NS1 Antigen 
 
15(15%) 16(16%) 
IgM Antibody 
 
15(15%) 49(49%) 
IgG  Antibody 
 
24(24%) 51(51%) 
  
From  a  total  of  of  100  cases,  15(15%) cases  was  positive  for  NS1 
antigen,15(15%) was  positive  for  IgM antibody   and  24(24%) was  
positive for  IgG antibody  by rapid  ICT. ELISA  was  able  to  detect 
16(16%),49(49%) and 51(51 %)cases  with  NS1 Ag,IgM and IgG  Ab  
respectively.(Fig  15) 
 
 Fig 15  :Dengue  parameters  detected  by  ICT  and  ELISA 
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Table  8.  Distribution  of  positive  cases  by  ICT   and  ELISA 
PARAMETERS 
 
NO.OF POSITIVES 
ICT ELISA 
NS1 only 
IgM only 
IgG only 
NS1+IgM+IgG 
NS1+IgM 
NS1+IgG 
IgM+IgG 
9(23.7%) 
4(10.5%) 
12(31.6%) 
3(7.9%) 
1(2.6%) 
2(5.3%) 
          7 (18.4%) 
 
2(3.4%) 
5(8.5%) 
8(13.6%) 
13(22%) 
1(1.7%) 
0(0%) 
30(50.8%) 
 
Total 38 59 
 
 The  above  table  (fig 16 ) shows that  among  38  ICT  positive  
cases , 9 (23.7%)  showed  positive for  NS1 only , 4 (10.5%)  for  IgM  
only, 12 (31.6%) for IgG only , 3 (7.9%) for NS1+IgM+IgG ,1 (2.6%) for 
NS1+IgM , 2 (5.3%) for NS1+IgG  and  7 (18.4%)  were  positive  for  
IgM+IgG. 
           The  above  table  shows that  among  59 ELISA  positive  cases , 2 
(3.4%)  showed  positive for  NS1 only , 5 (8.5%)  for  IgM  only , 8 
(13.6%) for IgG only , 13 (22%) for NS1+IgM+IgG ,1 (1.7%) for 
NS1+IgM, 0 (0%) for NS1+IgG  and  30 (50.8%)  were  positive  for  
IgM+IgG. 
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Table  9 :   Distribution of primary/secondary infection in positive 
cases. 
 
 
Primary Dengue 
infection 
 
(NS1 ,IgM or  
NS1+IgM  
positive) 
Secondary Dengue 
Infection 
 
(NS1+IgG,IgM+IgG 
or IgG positive) 
Late stage of 
primary/early 
stage of 
secondary 
infection 
(NS1+IgM+IgG 
positive) 
NO. % NO. % NO. % 
ICT 14 36.7% 21 55.3% 3 7.9% 
ELISA 8 13.6% 38 64.4% 13 22% 
 
The above table shows the distribution of primary and secondary 
infections among Dengue positive cases. ICT was able to differentiate  
14(36.7%) and 21(55.3%)as primary and secondary infection respectively. 
Among the 59 ELISA positive cases 8(13.6%) showed primary infection 
and 38(64.4%) showed secondary infection. 3(7.9%) of ICT positive cases  
and  13(22%) of  ELISA  positive  cases  showed  positive  for  all the  three  
parameters( NS1+IgM+IgG)  which  indicates  that  the  patient  may  be  
either  in  the  late  stages  of  primary  infection  or  in early  stages  of  
secondary  infection.(Fig  17)   
The presence of high titre of IgG early in the course of the disease is  
considered  as  a criterion   for  secondary  infection. 
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Fig 16  :Distribution  of  positive  cases  by  ICT   and  ELISA 
 
 
Figure  17 :   Distribution of primary/secondary infection 
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Table  10. Comparison  of NS1 antigen by ICT and ELISA. 
 
ICT 
ELISA 
Positive Negative 
          Positive 
         Negative 
14 
2 
1 
83 
            Total 16 84 
 
Detection  of  Dengue  NS1  antigen  by  rapid  
immunochromatographic  card test  was  evaluated  for  its  sensitivity  and  
specificity  against  NS1 antigen  ELISA  as reference test. 
Sensitivity   = 87.5% 
Specificity   =98.8% 
Positive predictive value  =93.3% 
Negative predictive value   =97.6% 
               From   the  above  table , sensitivity  of  rapid  ICT  was  87.5%  
when evaluated against  NS1  antigen  ELISA , a  reference  test. Specificity 
was 98.8% compared to ELISA and positive and negative predictive value 
were 93.3% and 97.6% respectively. 
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Table 11. Comparison  of IgM  antibody  by ICT and ELISA. 
                          ICT                          ELISA     TOTAL 
Positive Negative 
Positive 
Negative 
14 
35 
1 
50 
15 
85 
Total 49 51 100 
 
Detection  of  Dengue  IgM antibody  by  rapid  
immunochromatographic  card test  was  evaluated  for  its  sensitivity  and  
specificity  against  IgM Capture  ELISA  as reference test. 
Sensitivity   = 28.6% 
Specificity   =98% 
Positive predictive value   =93.3% 
Negative predictive value  =58.8%  .           
    From   the  above  table , sensitivity  of  rapid  ICT  was  28.6%  
when evaluated against  IgM Capture  ELISA , as a  reference  test. 
Specificity was 98% compared to ELISA and positive and negative 
predictive value were 93.3% and 58.8% respectively. 
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Table  12. Comparison  of  IgG antibody  by  ICT and ELISA. 
                          ICT                          ELISA     TOTAL 
Positive Negative 
Positive 
Negative 
24 
27 
0 
49 
24 
76 
Total 51 49 100 
 
Detection  of  Dengue  IgG antibody  by rapid  
immunochromatographic  card test  was  evaluated  for  its  sensitivity  and  
specificity  against  IgG Capture  ELISA  as reference test. 
Sensitivity   = 47.1% 
Specificity   =100% 
Positive predictive value   =100% 
Negative predictive value  =64.5% . 
              From   the  above  table , sensitivity  of  rapid  ICT  was  47.1%  
when evaluated against  IgG Capture ELISA , a  reference  test. Specificity 
was 100% compared to ELISA and positive and negative predictive value 
were 100% and 64.5% respectively. 
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Table  13.Association of urban and rural area in positive cases. 
 Positive Negative Total 
No. % No. % No. % 
 
Urban 
Rural 
 
 
35 
 
24 
 
59.3% 
 
40.7% 
 
23 
 
18 
 
56.1% 
 
43.9% 
 
58 
 
42 
 
58% 
 
42% 
Total 59 100 41 100 100 100 
 
The above table shows  that  out of 59 ELISA positive cases 
35(59.3%) cases belong to urban area and 24(40.7%) to rural area . In 
Dengue negative cases , 23(58%) cases  reside  in  urban  and  18(43.9%) in  
rural    area. The   association  of  cases  living  in  urban  and  rural  area  
was  found to be statistically  not  significant. (Fig  18) 
Figure  18 .Association of urban and rural area in positive cases. 
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Table  14. Sex wise distribution among positive cases. 
Sex Positive cases 
No. % 
Male 
Female 
35 
24 
59.3% 
40.8% 
Total 59 100 
 
Sexwise distribution of  Dengue  positive cases in the above table 
shows that males were more affected than the females(fig  19). Out of 59 
positive cases detected  by ELISA,35(59.3%)  were  males  and 24(40.8%) 
were  females . The  ratio  of male  to  female  was  found  to  be   1.5:1. 
 
Figure 19. Sex wise distribution among positive case
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Table  15. Age wise distribution among positive cases. 
Age (in years)                        Positive cases 
No. % 
11-20 
21-30 
31-40 
41-50 
51-60 
61-70 
28 
17 
9 
4 
1 
0 
47.5% 
28.8% 
15.3% 
6.8% 
1.7% 
0 
Total 59 100 
 
The  above  table (Fig 20) shows  that  majority  of  positive  cases   
are in  the  age  group of  11-20  years . Out  of  59  Dengue  positive  cases  
shown  by  ELISA, 28 (47.5%)  were  in  the  age  group  of  11-20  years . 
This  is  followed  by  a  higher  incidence   in  the  age  group  of  21-30  
years (28.8%). 
Figure  20. Age wise distribution among positive cases. 
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Table  16  :  Association  of  clinical  features  in  Dengue  positive cases. 
  Clinical 
features 
Dengue  
positive 
cases 
(n=59) 
Dengue 
negative 
cases 
(n=41) 
Total Test  of  
Significance(P<0.05) 
 Vomiting  38 
(64.4%) 
18(43.9%) 56 Significant 
Myalgia 46  (78%) 27(65.9%) 73 Not significant 
Headache 34  
(57.6%) 
22(53.7%) 56 Significant 
Bleeding 
manifestations 
10  
(16.9%) 
 
9(22%) 
 
19 
 
Not  significant 
 
The  above  table (Fig 21) shows  the  association  of  clinical  
presentation  in   Dengue  positive  cases. Vomiting  was present  in  
38(64.4%) of  positive  cases ,myalgia  in  46(78%),headache  in 34(57.6%) 
and  bleeding  manifestations  in 10(16.9%) of  cases. Among  the  clinical  
features  vomiting  and  headache  was found  to  be  statistically  
significant.  
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Table 17 :  Laboratory findings  in  Dengue  positive cases. 
Haematological tests Dengue  
positive 
cases 
(n=59) 
Dengue 
negative 
cases          
( n=41) 
Total Test  of  
Significance(P<0.05) 
Thrombocytopenia 9(100%) 41(100%) 100 Significant 
Leucopaenia 23(39%) 8(  19.5%) 31 Significant 
Elevated  Haematocrit 26(44.1%) 11(26.8%) 37 Significant 
Elevated  Liver  
Enzymes 
10(16.9%) 1(2.4%) 11 Significant 
 
Association  of  laboratory  findings  in  Dengue  positive  cases  are  
shown  in  the  above  table. The   association  of  thrombocytopenia, 
leucopaenia, elevated haematocrit (Hct)  and  elevation  of  liver  enzymes  
among  Dengue  positive  and  negative  cases  were  found  to  be  
statistically  significant.(Fig 22) 
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Table 18  :  Association  of  USG  findings  in  Dengue  positive  cases. 
USG 
findings 
Dengue  
positive 
cases 
(n=59) 
Dengue 
negative 
cases 
(n=41) 
Total Test  of  
Significance(P<0.05) 
 Ascites   11 (18.6%) 2( 4.9%) 13 Significant 
Pleural  
effusion 
6   (10.2%) 3(7.3%) 9 Not significant 
GB wall 
edema 
8   (13.6%) 1(2.4%) 9 Significant 
 
USG  findings  such  as  ascites 11(18.6%),pleural  effusion6(10.2%) 
and GB wall edema 8(13.6%) in  Dengue  positive  cases  are  shown  in  the  
above table. Among  the  Dengue  positive  and  negative  cases  ascites  and  
GB wall edema  was  found  to  be  significant  statistically.(Fig 23) 
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Figure  21:  Association  of  clinical  features  in  Dengue  positive  cases 
 
 
 
Figure  22:   Laboratory  findings  in  Dengue  positive  cases. 
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Table 19 :Distribution of  laboratory and  USG findings  in 
Primary/Secondary Dengue  cases 
  Findings Primary  
Dengue 
infection 
Secondary 
Dengue 
infection 
Late stage of 
primary/early 
stage of 
secondary  
infection 
Total 
positives 
Thrombocytopenia 8(13.6%) 38(64.4%) 13(22%) 59 
Leucopaenia 3(13%) 16(69.6%) 4(17.4%0 23 
Elevated  Hct 4(15.4%) 17(65.4%) 5(19.2%) 26 
Elevated  Liver  
Enzymes 
1(10%) 7(70%) 2(20%) 10 
 Ascites  2 (18.2%) 6(54.6%) 2(18.2%) 11 
Pleural  effusion 2(33.3%) 2(33.3%) 2(33.3%) 6 
GB wall edema 2(25%) 5(62.5%) 1(12.5%) 8 
 
The   above  table(Fig 24)  shows  the  distribution  of  laboratory  and  
USG  findings  among  primary,secondary  and  during late  stage  of  
primary  or  early  stage  of  secondary  Dengue  infection. All the  findings  
were  found  to  be  higher  in  secondary  Dengue  infection  when  
compared  with  the  others.  
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Figure  23:  Association  of  USG findings  in  Dengue  positive  cases. 
 
 
 
Figure 24:Distribution of laboratory and  USG findings  in 
Primary/Secondary Dengue  cases 
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6. DISCUSSION 
 
Dengue is one of the major re-emerging viral infections. Though the 
disease is usually seen in endemic areas, many epidemics involving 
continents and pandemics have been witnessed by the world.For  the  past 
few decades, there has been a significant raise in the number of cases , 
disease severity and geographic spread .This is mainly due to drastic change 
in the environment  which  in  turn is  due to rapid urbanization and increase 
in transportation  across  several parts of India .Dengue fever has been 
known to be endemic in  India for more than 20 years as a benign and self-
limited disease.During recent years, severe form of Dengue infection known 
as DHF  manifests  more frequently which leads to increase in the number 
of hospitalization of the affected patients .Outbreaks of Dengue fever are 
reported  almost  every  year in  India .Detection of all four Dengue 
serotypes in India has now rendered India hyper endemic .An early 
diagnosis of the disease aids in effective management and prevents further 
complications like DHF and DSS .With this background, the present study 
attempts to evaluate the  efficacy  of  rapid immunochromatography  test  
against  ELISA in  diagnosing  acute Dengue infection . 
6.1 Age and sex wise distribution in study group 
The  present  study  shows that out of 100 suspected  cases, males 
were found  to  be  predominant   than  the  females  in  the  ratio  of  1.4 : 1. 
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     Male preponderance  were  observed  in similar  studies  conducted  
by   Manisha Patankar et al
22
 and  Gargi Ghosh et al 
21
. This may be the 
representation of  those  who  visited  the  hospital  to  seek  healthcare  
rather  the  truely  infected  population. 
      The  suspected  cases  who  were  seeking  medical  attention  
belonged  to  the  age  group  of  11-20 years  in  the  present  study. This  
result  is  similar  to  the  study   conducted  by  Gargi Ghosh et al 
21
. 
           Demographic characteristics like age distribution and gender 
differences are important for the successful planning of public health 
programmes and effective control of communicable diseases
120
. 
6.2 Distribution of associated clinical features ,laboratory  and USG  
findings in study group. 
            The  current  study  shows that  among  the  100  Dengue suspected 
cases  ,55%  was associated with  vomiting , (55%) with headache, 73 %  
had  myalgia, 19%  had  bleeding  manifestations , 11%  had  abdominal 
pain  and 13% presented with  URI  .The  laboratory  and  USG  findings 
shows that  haematocrit (Hct) was  found  to  be  elevated  in  37%  and  
31%  presented  with  leucopenia and  11%  had  liver  enzymes  elevated , 
13%  had ascites,9% had pleural effusion,9% with GB wall edema and  8% 
presented  with  hepatomegaly which  was  similar  to  the  study   
conducted  by  NP Singh et al 
74
and  in contrast to a study by Ghargi ghosh 
et al
21
. 
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6.3 Prevalence  of  Dengue  infection 
             In the present study Dengue viral infection accounts for 59% of 
hospitalization in adults with acute febrile illness .The prevalence is 
comparable to a study conducted by  Chakravarti et al
23
(60.7%)in 2011.
 
Vijayakumar et al 
13
in  his  five  year  study  conducted  at  Christian 
Medical College , Vellore  observed   that  the   prevalence  of  Dengue  
infection was  43.5%  in  1999 and  55.1% in  2003   whereas  in  the 
intervening  years  the  percentage  was  just  above  25 %.  
          In  contrast  there  was  a  high  prevalence  of  Dengue  infection  
(65.2%) in a  study conducted  by  Siraj A. Khan et al
24 
in  a  hilly  region  
of  Andhra Pradesh. 
6.4 Comparison  of  ICT  and  ELISA. 
The  sensitivity  of  rapid  ICT  was  62.7%  when evaluated  against  
ELISA , as  a  reference  test. Specificity of   ICT was 97.6% compared to 
ELISA and positive  and negative predictive  value  were  97.4%  and  
64.5%  respectively.  
The sensitivity  of the  rapid ICT  in present study correlates well with 
that of  a  study conducted  by  Pramiladevi et al
121 
(68.75%)  but  with  
lower specificity than  that  of the  present  study.  Similar  study   by  Scott 
R. Fry et al
122
 showed  sensitivity  and  specificity  of rapid  ICT as  69.2%  
and  96%  respectively.  
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Hence all the samples negative by ICT have to be confirmed by a 
more sensitive  test  like  ELISA  or  PCR.  
6.5 Detection  of  Dengue  parameters   by  ICT  and  ELISA 
From  a  total  of  of  100  cases,  15(15%) cases  were  positive  for  
NS1 antigen,15(15%) positive  for  IgM antibody and 24(24%) cases 
positive for  IgG antibody  by rapid  ICT. ELISA  was  able  to  detect 
16(16%),49(49%) and 51(51 %)cases positive for  NS1 Ag,IgM and IgG  
Ab  respectively. 
The  present  study  shows  that  ELISA was able  to  detect  more  
IgM and  IgG positive  cases  than  the  ICT  whereas there was  no  much  
of  difference between ICT  and  ELISA  for NS1  antigen  detection . 
Hence  ICT  can  be  used  in  NS1  detection  in  the  early  stages  of  the  
diseases.   
6.6 Distribution  of  positive  cases  by  rapid  ICT and ELISA. 
         The  present  study shows that  among  38  ICT  positive  cases , 9 
(23.7%)  showed  positive for  NS1 only , 4 (10.5%)  for  IgM  only , 12 
(31.6%) for IgG only , 3 (7.9%) for NS1+IgM+IgG ,1 (2.6%) for NS1+IgM 
and 2 (5.3%) for NS1+IgG.   
         In  contrast , a  study  by Bala et al
133
showed  that out  of  78  ICT 
positive cases  26 cases (33.33%)  was positive for NS1 antigen  only, 7 
cases (8.97%) positive for IgG + IgM , 7 cases (8.97%) and 27cases (34.6%) 
were  positive  for  NS1 +IgG  and  NS1+IgM+IgG  respectively. 
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 Results  reported  in  another  comparative  study  by  GargiGhosh et 
al
21
 showed  that   of   320  samples  positive for one or more Dengue 
parameters by  ICT,165 (51.56%) were positive for NS1 only, 73 (22.81%) 
were positive for only IgM, and 39 (12.2%) were positive for IgG only ,3 
(0.93%) were positive for NS1 + IgM + IgG, 33 (10.31%) and 7 (2.19%) for  
NS1 + IgM and  IgM + IgG  respectively. 
In the  present  study , distribution  of  positive  cases  by  NS1 
antigen ELISA,MAC  and  GAC  ELISA  shows    that  among  59 ELISA  
positive  cases , 2 (3.4%)  showed  positive for  NS1 only , 5 (8.5%)  for  
IgM  only , 8 (13.6%) for IgG only , 13 (22%) for NS1+IgM+IgG ,1 (1.7%) 
for NS1+IgM , 0 (0%) for NS1+IgG  and  30 (50.8%)  were  positive  for  
IgM+IgG. 
          In a  similar  study  by  Chakravarti et  al
123
 in  2011 observed  that  
there  is  a gradual  increase  in  positivity  toward  the end of  the  acute  
phase of the disease when  combining  NS1 antigen  ELISA  (detectable in  
patient sera  from Day 1 onwards)  and Dengue IgM ELISA ( detected from  
Day 3 onward ).  
 The  present  study  shows  an  increase  in  positivity  when a  single  
sample obtained from  the  patient  was  subjected  to  a  combination  of  
antigen(NS1) and  antibody(IgM  and  IgG) detection rather than  subjecting  
to  detection of  single  parameter  when  one  or  more  biomarkers  are  
likely  to  be  missed. 
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6.7 Distribution of primary/secondary infection in positive cases. 
The  present  study shows  that  the distribution of  primary and 
secondary infections among Dengue positive cases. ICT differentiates 
14(36.7%) and 21(55.6%) as primary and secondary infection respectively. 
Among the 59 ELISA positive cases 8(13.6%) had  primary infection and 
38(64.4%) had secondary infection.  3(7.9%) of ICT positive  cases  and  
13(22%) of  ELISA  positive  cases  showed  positive  for  all the  three  
parameters NS1+IgM+IgG. 
Hossain et al.
124
and  Sultana N et al
12
 also  reported  in a  similar  
study  where  secondary  infections  were  more  prevalent  than  the  
primary  infections.  
Present  study shows  that  majority  of  ELISA  positive  cases  had 
secondary infection  which  may  be  due  to the  sequential circulation of 
different Dengue serotypes during various outbreaks of Dengue infection. 
Prior sensitization  by a  heterologous  Dengue  serotype  increases the  risk 
of  acquiring  more  severe  form of  the  disease  in  secondary  infection  
than   the   primary infection. Thus detection  of  Dengue  secondary  cases  
at  the  early  stage of  infection is of  major  importance  to  avoid  fatal  out 
comes.
 
The rapid  ICT  provides  just  a hint  about  the primary or secondary 
infection  but   lacks  in  giving  quantitative  information.  
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 6.8 Comparison  of  NS1 antigen by ICT and ELISA. 
The sensitivity of ICT in detecting NS1 antigen was low (87.5%) 
while the specificity was 98.8% when evaluated against NS1 antigen 
ELISA. Similar low sensitivity was reported by  Philippe Dussart et al 
125
which  showed 81.5%  but  with a  specificity  of  100%  .   
Based on the study by Hang et al.
108
, 2009,false-negative results may 
occur  due to the formation of immune complexes of  NS1 antigen with IgG, 
especially during secondary infections, when  there is non- availablility of 
target antigen to the  monoclonal  antibody  from  ELISA. 
Dussart et al
125
 stated  that rapid tests  are  being  used for the 
detection of Dengue NS1 antigen  and  it  provides  a promising  alternative  
for  those  tests  that  are  based  on  antibody  detection . 
6.9 Comparison  of  IgM antibody  by ICT and ELISA. 
The sensitivity of ICT was very low (28.6%) while the specificity was 
high (98.8%) when evaluated against MAC ELISA. Similar low sensitivity  
and high  specificity was reported by Hunsperger et al
103
(sensitivities ranged 
from 21% to 99% and specificities ranged from 77% to 98% ),Hasan et al 
126
(Sensitivity / specificity  was 16.67/88.89% ) and Stuart D. Blacksell et  
al
104
(sensitivity and  specificity ranged from 6.4% to 65.3% and 69.1% to 
100% respectively).  
Vorndam and Kuno et al,
82
 observed that during a secondary 
infection, about 20% of patients do not have IgM at detectable levels. 
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Vasquez S et al.
102
  stated  that  different  kits  used  for  IgM detection  
have  variability  in their sensitivity  and  specificity.The sensitivity and 
specificity of IgM based assays is strongly influenced  by  the  quality  of  
the  antigen  used  and  can  vary greatly between commercially available  
products
127
. 
6.10 Comparison  of  IgG antibody  by ICT and ELISA. 
The sensitivity of  ICT  was  low (47.1%) while the specificity was 98 
% when evaluated against GAC ELISA. Similar low sensitivity and high  
specificity  was  reported  by  Hasan et al
126
 (sensitivity / specificity  was 
33.3/100%). 
IgG is a less reliable marker in the diagnosis of Dengue 
infection. Both clinical and sub-clinical infections produce IgG  that  
persists for several years  which  affects the interpretation of  test  results
23
.It  
is highly likely that IgG levels could be higher in endemic areas because of 
bites from infected mosquitoes.The results of the study  by Tran 
ThiThanhNga et al
128
confirms  that rapid tests  that  are  based  on antibody 
detection   still  have  limited value for diagnosing  acute Dengue infection.  
 6.11 Association of urban and rural area in positive cases. 
The  present  study  shows  that  out of 59 ELISA positive cases 
35(59.3%) cases belong to urban area and 24(40.7%) to rural area . 
Aedes aegypti, the main vector species of Dengue fever/Dengue 
haemorrhagic fever (DHF) is commonly found in urban areas which can be 
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attributed to the availability of breeding sites such as water storage 
containers due to poor management of water and limited supply of drinking 
water, non degradable tyres, long lasting plastic containers and ineffective 
community participation in eliminating the breeding places. However, new 
foci are a major concern for public health by affecting the epidemiology of 
this disease such as rural and semi-urban areas, which may be linked to 
climate change. 
6.12 Sex wise distribution among positive cases. 
Sexwise distribution of Dengue positive cases in the present  study  
shows that males are more affected than the females. Out of 59 positive 
cases detected  by ELISA,35(59.3%) were male and 24(40.8%) were female  
in  the  ratio  of  1.5:1. 
Smitasood et al
75
,ManishaPatankar et al 
22
 and Ahmad Nizal MG et al
72
also  
showed  similar  results  where  males  are  more  predominant  than  the  
females.  
High prevalence amongst males is probably due to more outdoor  
activities  in comparison to females which results in more exposure to day 
biting mosquitoes.  Thelower infection rates in females of Asian community 
might be attributed to lower reporting rate and the fact that they remained 
stationed at home and are less exposed to this vector born infection.
120 
In contrast , studies  by  Paramasivan et al
28
 and  Siraj.A khan et al
78
 
reported  that  females  were  more  predominant  than   the  males.Siraj.A 
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khan et al
78
 stated  that  the vector mosquitoes (Aedes sp.) are  mainly  
domestic  and  peridomestic  in  nature  and  females/house wives  have  a  
increase chance  of  exposure  to  mosquito bites.  
6.13 Age wise distribution among positive cases. 
The  present  study shows  that   the  majority  of  positive  cases   are 
in  the  age  group of  11-20  years . Out  of  59  Dengue  positive  cases  
shown  by  ELISA, 28 (47.5%)  were  in  the  age  group  of  active  adults 
11-20  years. 
Aneela Altaf Kidwai et al
120
 ,Sharma et al 
19
 and  Manisha Patankar et 
al
22
  also reported  the  same  results in  which  active  adults  forms  the  
majority  of  the  positive  cases. As  active  adults  are  doing  more  
outdoor work activities , there  are  more  chances  of  them  being  infected. 
Sharma  et al 
19
proposed  that  exposure to multiple serotypes over a 
period of  time results in immunity development,i.e., multitypic immunity in 
adults. The shift in the age preponderance may  be  due  to the accumulation 
of multitypic immunity in the adult population. It is suggested that over a 
period of time , as the co-circulation of multiple Dengue serotypes increases 
in a particular geographic area , adults have a lower chance of remaining 
susceptible to infection. This results in the young population susceptible to 
Dengue infection.Therefore, monotypically immune  individuals  are  more  
likely  to  be  from  younger  age  groups. 
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6.14 Association of  clinical   features  in Dengue  positive  cases. 
The current study shows that vomiting was an associated feature in 38 
(64.4%)  myalgia  46(78%)  of  59  Dengue  positive  cases as shown  by a 
similar study Ahmad Nizal MG  et al
72
 . In  the  present  study, among  59  
ELISA  positive cases , 34  (57.6%)  presented  with  headache as an 
associated feature  similar  to  Sanjay Kumar  Mandal et al
129
.Headache and 
retro-orbital pain are well known features in  Dengue fever  that occurs  
mostly  from  systemic  inflammatory  mediators. The  current  study  shows 
that bleeding manifestations  was an associated feature  in  10 (16.9%)  of  
59  Dengue  positive  cases  which is  similar  to  Sanjay Kumar Mandal et 
al
129
. Bleeding  diathesis , a known feature of Dengue fever is due to low 
platelet count and leakage from blood  vessels.Although  thrombocytopenia  
was  a constant finding,  no correlation  could  be  established  between  the  
platelet  count and bleeding manifestations, indicating that other features, 
such as a disturbance in platelet function and capillary fragility, contribute 
to the bleeding diatheses.
74 
6.15 Association  of  laboratory  findings  in  Dengue  positive  cases. 
 The current  study  shows  that among  the  Dengue  positive  cases, 
thrombocytopaenia  and  leucopenia  were  present  in  59(100%)  and  
23(39%) of  cases  respectively. Haematocrit  and  liver  enzymes  were  
elevated  in 26(44.1%)  and 10(16.9%) of  cases  respectively. 
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Similar  results  were  obtained  in a study  by NP Singh et al
74
 that  
showed  thrombocytopenia (with a platelet count <100,000/µl) was found in 
about 61.39% of cases  and  the  liver enzymes  were  elevated in 16% of 
cases (16 of 100). The  factors  responsible  for thrombocytopenia are bone 
marrow suppression, immune mediated clearance and spontaneous 
aggregation of platelets to virus infected  endothelium .Elevation  of Liver  
enzymes  could be due to virus induced damage of the hepatocytes , shock , 
hypotension or associated liver disease
74
. 
6.16 Association  of  USG findings  in   Dengue  positive  cases. 
Present  study shows  that  the USG findings  such  as  ascites ,  
pleural effusion  and GB wall edema are  present in 11 (18.6%),6 (10.2%)   
and  8 (13.6%)   of  positive  cases  respectively.  
           In    contrast , a  study   by  Sanjay Kumar  Mandal et al
129
  showed  
ascites  and  pleural effusion  in  8.1% and 18.9% of  cases  respectively. 
Another  contrast study  by  P M VenkataSai et al
130
  reported  that  nearly 
all  Dengue positive cases  were  detected  with  GB wall edema(100%)  
during  the  first  week  of  fever.                            
Ascites and  pleural effusion  results  from  capillary  leak  syndrome.  
Ultrasound features of thickened gall bladder wall, ascites and pleural 
effusion  strongly favours  the diagnosis  of  Dengue fever. In a study  by 
VenkataSai et al
130 
,ultrasonographic yield was found to increase in the later 
stages of the disease. Repeat ultrasonography performed on the 5
th
 to 7
th
 day 
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detected pleural effusion, ascites ,hepatomegaly  and  GB wall edema  in  
significantly  higher  number of  patients  with  Dengue fever. 
6.17 Association of laboratory and USG findings in Primary/Secondary 
Dengue  cases. 
           The  laboratory and  USG findings were  found  to  be significantly  
higher  in numbers in patients with secondary Dengue  infection  when  
compared  to primary infection.It seems to be almost specific for diagnosing 
Dengue Hemorrhagic Fever. These sonographic findings are more common 
in higher grades of clinical severity of Dengue fever. Hence, 
ultrasonographyis useful for early prediction of the disease severity and thus 
help in more meticulous management of the patients which enables to 
reduce morbidity and recommend close follow up. During an epidemic the 
ultrasound findings of Gall Bladder wall thickening with or without 
polyserositis in a febrile patient should suggest the possibility of  Dengue 
Fever / Dengue Hemorrhagic Fever
131.
 
             A rising HCT is a marker of plasma leakage in Dengue infection 
and helps to differentiate between DF and DHF but it can be masked in 
patients with concurrent significant bleeding and in those who receive early 
fluid replacement. The frequency and degree of elevation of the liver 
enzymes are higher with DHF compared to DF
132
. 
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 Hence, the  baseline  HCT , leucopenia  and  liver  enzymes should be 
looked  for as early as possible in all patients with suspected Dengue and 
must be monitored  as  the  disease  progresses.
 
        The  current  study  shows  that  among  the distribution of ELISA 
positive cases 24(40.8%) and 35(59.2%) cases presented as DF and DHF 
respectively .This  study  is  in  accordance  with  the  study  conducted by  
Nizal MG et al
72
and   in  contrast  to  Sharma Y et al
19
.The  present  study  
shows  more  prevalence  of  secondary  infection  than  that of  primary  
infection.DHF occurs  more commonly in  secondary infection.As the  
present  study  shows  more  prevalence  of  secondary  infection,  more 
cases could have presented with  DHF,a severe form of  the  disease when  
compared  to  DF which  is  mild  and  self-limiting.None  of  the  cases 
presented  with  DSS .   
 As there is no prevention in the form of any vaccine for Dengue, early 
diagnosis and treatment is recommended for preventing complications. 
Immuno chromatographic tests for Dengue NS1 antigen and IgM  and IgG 
antibody show a high specificity with poor sensitivity, especially with 
respect to the detection of IgM  and  IgG. The rapid diagnostic test is 
convenient, easy to use and the results are obtained within 15 minutes for 
ambiguous results. All  the  three  parameters when detected, differentiates  
primary  and  secondary  Dengue  infection  and  this reduces the need  for  
paired  sera in diagnosing secondary infection,as secondary  infection leads  
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to complications like DHF/DSS and  subsequent mortality. Thus, while the 
rapid test can be more feasible in small peripheral laboratories  and in field 
situations  but in well-established laboratories in India, considering its 
moderate performance, this   device is not  used  as  an  stand  alone  test  in  
Dengue  diagnosis  but  can  be  supplemented  with  more  sensitive  and  
specific  test  such  as  ELISA   on  those  samples to ensure both rapidity as  
well as quality of  reported results..Highly suspicious cases should be 
subjected to investigations with higher sensitivity & specificity, though the 
results take little more time. 
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7. SUMMARY 
 
The present study aimed at detecting the prescence of Dengue NS1 
antigen,IgM  and  IgG antibodies  in  serum  samples of  adults  admitted  
with  febrile  illness  suspicion  of  Dengue infection . 100 cases of  
hospitalized adults were included in the study and samples were tested by 
both rapid Immunochromatographic test and ELISA for  the  three 
parameters(NS1 antigen,IgM and  IgG  antibodies).The rapid card test was 
evaluated against ELISA in detection of  Dengue  infection in serum 
samples.The  factors  associated with  in children were analysed. 
 Of the 100 samples  tested  48 % of  adults with acute febrile illness 
belonged  to  the  age group of 11-20  years. 
 59% were male and 41% were female in the study group. 
 Vomiting, myalgia, headache, abdominal pain, bleeding 
manifestations and URI were the associated clinical features in adults  
with  fever. 
 Out of 100 adults tested by rapid ICT, 38% were positive for Dengue 
infection(NS1 antigen,IgM and  IgG  antibodies)in the serum sample. 
 When the same samples were tested by ELISA(Positive for any one  
of the  three parameters), positivity was 59%. 
  37 samples  positive by ICT were positive by  ELISA also.  
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 Rapid ICT had a sensitivity of 87.5%, Specificity of 98.8%  for  NS1  
antigen  when evaluated against NS1 antigen  ELISA as gold 
standard. 
 The positive predictive value  of ICT was 93.3% and the negative 
predictive value was 97.8 %  for  NS1  detection. 
 Rapid ICT had a  very  low sensitivity of 28.6%, Specificity of 98%  
for  IgM antibody when evaluated against MAC  ELISA as gold 
standard. 
 The positive predictive value  of ICT was 93.3% and the negative 
predictive value was 58.8 %  for  IgM  detection. 
 Rapid ICT had a  low sensitivity of 47.1%   and  had  a  very  good 
specificity of 100%  for  IgG antibody when evaluated against GAC  
ELISA as gold standard. 
 The positive predictive value of ICT was 100% and the negative 
predictive value was 64.5 %  for  IgG  detection. 
 Adults from  urban  area  showed  positivity (59.3%) higher than 
those  from  rural  area (40.7%) 
 Maximum number of  positive cases (47.5%)  occurred in the age 
group of 11-20 years. 
 Male preponderance(59.3%) were present among  the  positive  cases  
 Vomiting was present in 64.4% of  Dengue positive cases. 
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 Myalgia  was observed in 78% of positive cases. 
  Headache was  found to be  associated  in 57.6% of  positive  cases. 
 Bleeding manifestation  was  present  in 16.9% of  positive  cases. 
 USG findings  among  the  positive  cases  showed  ascites (18.6%), 
pleural effusion (10.2%), and GB wall edema (13.6%). 
 13.6%  showed  primary  infection  and  64.4%  showed secondary 
infection 
 DF and DHF was  presented  in  40.8%  and  59.3% of  positive  cases 
respectively. No case presented  with  DSS  in  the  current  study.  
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8. CONCLUSION 
  A total of 100 cases were studied. 
  The rapid immunochromatography test has very less sensitivity and 
specificity is  satisfactory . 
  The PPV is  satisfactory  but  NPV is  less  satisfactory. 
  The rapid test can be used as a screening tool in situations of 
outbreaks but  not as a diagnostic test. 
 All  samples  should be subjected  to  both  antigen(NS1) and  
antibody (IgM  and  IgG) testing  to  increase  the  positivity   rate  
and  to  prevent  missing  of  positive  cases.  
 Cases with higher degrees of suspicion are to be subjected to 
diagnostic  tests with higher sensitivity & specificity  like  ELISA  
and  PCR. 
 The commercially available rapid immunochromatographictest  
device can be used as a screening device during Dengue outbreaks. It 
should not be used as a standalone device for diagnosis of Dengue. It 
is recommended that highly suspicious cases should be subjected to 
tests with higher degree of accuracy. 
 Further molecular studies are essential to know the accurate 
information of Dengue serotypes which will be helpful in formulating 
vaccines in future. 
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Previous episode  : 
Family h/o dengue  : 
Past h/o hospitalization : 
FEVER  
Duration  
Rigor  
Vomiting  
Retro orbital 
Pain 
 
Back PAIN 
 
 
MYALGIA 
 
 
ARTHRALGIA 
 
 
MACULOPAPULAR 
RASH 
 
STARTED ON 
 
 
SPREAD  
HAEMORRHAGIC  MANIFESTATION  
Perechiae  
Echymosis  
Bleeding guns  
GIT bleeding  
Haematuria  
RESPIRATORY SYMPTOMS  
Sore throat  
Rhinitis  
Cough  
S SYMPTOMS 
OF HEPATITIS 
 
Jaundice  
SYMTOMS OF CNS INVOLVEMENT  
Altered Consciousness  
Focal neurological deficit  
Fits  
SYMPTOMS OF SHOCK  
Hypothermia / Sweating  
Restlessness  
Somnolence  
H/O Mosquito bite 
Presence of Stagnant water around the living area. 
Proper domestic water  storage. 
General Examination. 
 
Built  Petechiae  Weight  
Anaemia  Rash  Temperature  
Jaundice  Conjunctival  
congestion 
 Heart rate  
Cyanosis  Pedal edema  RR/Sa O2  %  
Lymphadenopathy  Torniquet test  Blood Pressure  
Systemic Examination 
CVS  
RS  
CNS  
Abdomen  
Investigations:- 
Hb  RBS  
Tc  Sr.Protein  
Dc  Urea  
ESR  Creatinine  
HCT%  Urine 
deposits 
 
Platelets  
LFT  
Blood 
Culture 
 Typhoid  Leptospirosis  
Malaria  Chikungunya  JE  
USG  
CXR 
Serology 
Tests  IMMUNOCHROMATOGRAPHY               ELISA 
NS1 
IgM 
IgG 
  
S.No Age Sex
Fever 
duration 
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h
e
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m
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al
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ai
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l e
d
em
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↑
  L
FT
↑
  H
C
T
Le
u
co
p
en
ia
Th
ro
m
b
o
cy
to
p
en
ia
NS 1 IgM IgG NS1 IgM IgG
NS1                
Cut off 
(0.361)
IgM        
Cut off 
(0.607)
IgG                
Cut off 
(0.397)
1 13 MALE 7 P N P N P N P P P N N + + - - - - + + 0.028 2.4 2.44
2 25 FEMALE 5 N N P N P N P N P P P - + - - + - + + 0.059 1.71 2.27
3 23 FEMALE 5 P N P N P N N N N P N + + - - + - + + 0.008 1.06 2.31
4 48 MALE 6 P N P P N malena N N N N P + + - - - - - - 0.001 0.57 0.235
5 42 FEMALE 3 N P P N N N N N N N N + + - + - - + + 0.008 1.636 1.665
6 20 MALE 4 P P P N N N N N N N P + + - - - - + + 0.006 2.283 1.938
7 15 MALE 4 N N P N N N P N P P N + + - - - - + + 0.008 0.742 2.229
8 16 MALE 3 P N P N N N N N N N P - + - - + - + + 0.008 2.305 2.15
9 15 MALE 3 P P P P N N N N N N P + + - - + - + + 0.001 2.325 1.511
10 20 FEMALE 3 N N N N N N N N N N N - + - - - - - + 0.005 0.185 1.492
11 17 MALE 4 P N P N N N N N N N N - + - - - - + + 0.054 2.193 2.275
12 23 FEMALE 4 P P P N N N P N N N P - + - - + - + + 0.036 2.313 2.336
13 22 FEMALE 11 N P P N N N N N N N N - + - - - - - - 0.058 0.228 0.21
14 13 FEMALE 5 P P P N N N N N N N P - + - - + - - + 0.044 0.54 2.328
15 20 MALE 5 N N N N N Haematuria N N N N P - + + - - - - - 0.038 0.267 0.306
16 48 MALE 7 N N N N N malena N P N N N - + - - - - - - 0.032 0.272 0.212
17 58 MALE 30 N N P N N N N N N N N - + - - - - - - 0.047 0.18 0.166
18 35 MALE 4 N P P P N N N N N N P - + - + - - + + 0.044 2.272 2.325
19 21 MALE 4 P P P N P malena N N N N P + + + - - + + + 2.361 2.198 2.305
20 26 FEMALE 7 N P P N N N N N N N N + + - - - - - - 0.034 0.164 0.105
21 58 FEMALE 7 P P P N N N N N N N P - + + - - + + + 2.127 2.23 2.363
22 22 FEMALE 4 P P P N N N N N N N P - + - - - - + + 0.116 2.301 2.31
23 20 FEMALE 4 N N P N N bleeding gums N N N P N - + + - - + + + 2.381 0.795 2.224
24 38 FEMALE 6 P P P N N N N N N N N - + - - - - - - 0.024 0.159 0.086
25 23 FEMALE 4 P P P P N malena N N N P P - + + - - + + + 2.286 2.417 2.381
26 23 MALE 7 P P P P N N N N N P N - + - - - - - - 0.027 0.203 0.184
27 70 MALE 7 P P P N P N N N N N P - + - - - - - - 0.042 0.181 0.247
28 33 MALE 7 P P P P N N N N N N N - + - - - - - - 0.03 0.223 0.223
29 32 FEMALE 6 P P P N N N N N N P N - + - - - - - - 0.031 0.177 0.1
30 27 FEMALE 4 P P P N P N N N N P N + + - - - - + + 0.031 2.158 2.219
31 34 MALE 7 N P P N N malena N N N N N - + - - - - + - 0.033 0.662 0.208
32 14 FEMALE 5 P P P N N N P P N P N + + - - - - - - 0.034 0.337 0.164
33 18 FEMALE 4 P P P N N N N N N N N - + - - - - - - 0.032 0.169 0.275
34 13 FEMALE 4 N N P N N N N N N N N + + - - - - - + 0.039 0.416 1.727
ELISARapid ICT OD VALUE
MASTER CHART
35 35 FEMALE 8 P P P N N malena N P N P P - + - - + - + + 0.041 2.153 2.279
36 40 MALE 2 N N P N N N N N N N P - + + - - + - - 2.413 0.196 0.086
37 15 FEMALE 5 P P P N N N N N N N N + + - - - - + + 0.032 0.994 1.75
38 32 MALE 4 P P P N N N N N N N P - + + - - + + + 2.334 2.057 1.145
39 25 MALE 3 P N P N N N N N N N P - + - + - - + + 0.03 0.808 1.588
40 21 FEMALE 3 P P P P P
malena.bleeding 
gums
N N N P P - + - - - - - - 0.031 0.211 0.234
41 36 FEMALE 5 P N N P N N N N N N N + + - - - - + + 0.026 0.887 1.231
42 52 FEMALE 10 N N P N N N N N N N N - + - - - - - - 0.064 0.203 0.143
43 31 FEMALE 7 P P P N N N N N N N N + + - - - - + + 0.034 1.053 2.082
44 26 MALE 3 N P P N N N N N N N N - + + + + + + + 2.364 2.302 2.304
45 40 FEMALE 5 N N P N N N N N N N N - + - - - - - - 0.028 0.144 0.302
46 27 FEMALE 3 P N P N N N P N P N N - + - - - - + + 0.029 2.144 2.296
47 22 MALE 7 N P P N N N N N N N N - + - - - - - - 0.029 0.157 0.16
48 14 MALE 3 P N N N P
malena,haemete
mesis
N N N N N - + - - - - - - 0.035 0.136 0.077
49 16 MALE 4 P P P N N malena N N N P P + + - - - - - - 0.025 0.174 0.21
50 25 FEMALE P N P N N Bleeding gums N N N N N + + - - - - + + 0.038 1.372 1.097
51 48 MALE 4 P P P N N N N N N N P - + - - - - - + 0.035 0.15 1.551
52 18 MALE 4 N P P N N N N N N N P + + - + + - + + 0.025 2.29 1.126
53 73 MALE 10 N N N P N N N N N N N - + - - - - - - 0.028 0.449 0.295
54 28 MALE 5 P N P N N N N N N N N - + - - - + - - 0.852 0.148 0.22
55 16 MALE 7 P N P N N N N N N N N - + - - + - - + 0.033 0.172 1.515
56 14 FEMALE 6 P N N N N N P P N N N - + + - + + + + 2.434 2.243 2.362
57 17 MALE 4 N N N N N N N N N N N + + - - + + + + 1.938 1.172 2.377
58 18 FEMALE 7 N N N N N N N N N N N - + - - - - - + 0.037 0.401 1.891
59 16 FEMALE 4 N N N N N N N N N N N - + - - - - - - 0.024 0.18 0.167
60 30 MALE 4 N P P P N N N N N N N - + - - - - - - 0.027 0.221 0.135
61 22 FEMALE 6 P N N N N N N N N N N - + - - + - + + 0.042 0.806 2.227
62 42 MALE 4 N N N N N N N N N N P - + - - + - + + 0.03 0.635 2.307
63 17 MALE 3 P N P N N N N N N N P + + + - - + + + 1.412 1.956 2.053
64 19 MALE 4 N N N N N N N N N N P - + - - - - - - 0.21 0.296 0.297
65 48 FEMALE 7 P P N P N N N N N N N - + - - - - - - 0.208 0.21 0.181
66 22 MALE 7 P N N N N N N N N N N - + - - - - - - 0.025 0.208 0.298
67 33 MALE 5 N P N N N N N N N N P + + + - + + + + 2.244 1.703 1.843
68 25 FEMALE 7 P P P N N N N N N N P - + - + + - + + 0.024 1.33 2.327
69 28 MALE 5 N P P N N malena N N N N P + + - - - - - - 0.039 0.173 0.176
70 34 FEMALE 5 N N N N N N N N N N N - + - - - - - - 0.02 0.167 0.25
71 29 MALE 7 N P P N N N N N N N P - + - + + - - + 0.047 0.175 2.323
72 14 FEMALE 4 P P P N N Bleeding gums P N P P N + + - + + - + + 0.049 1.775 0.145
73 31 MALE 7 P N P N N N N N N N P - + - - - - - - 0.024 0.304 0.164
74 14 FEMALE 4 N N N N N N N N N P N + + - - - - - - 0.027 0.174 0.187
75 58 FEMALE 5 N P P N N N N N N N N - + - - - - - - 0.028 0.353 0.115
76 17 MALE 3 P P P N N N N N N N N - + - - - - - - 0.026 0.263 0.18
77 35 MALE 4 P P P N N N N N N N N - + - - - - - - 0.05 0.156 0.398
78 16 MALE 6 N P N N N N N N N N N + + + + - + + + 2.315 2.325 1.133
79 20 MALE 5 N N P N N N N N N N P + + - + + - + + 0.175 2.254 0.205
80 25 MALE 7 N P P N N N N N N N N - + - - - - - - 0.04 0.452 2.315
81 25 MALE 4 N P P N N N N N N N P - + - - - - - + 0.028 0.532 1.213
82 13 MALE 5 P N P N N N N N N N N + + + + + + + + 2.437 2.289 0.154
83 35 MALE 10 P P P N N N N N N N N - + - - - - - - 0.068 0.152 0.284
84 19 MALE 7 P P P N N N N N N N N + + - - - - + - 0.065 0.742 0.229
85 18 MALE 4 N P P N N N N N N N N - + - - - - - - 0.062 0.23 0.91
86 24 MALE 5 N P N N N N N N N N N - + - - - - + + 0.072 1.907 0.145
87 50 MALE 14 P N N N N malena N N N N N + + - - - - - - 0.056 0.241 0.12
88 38 MALE 7 P N N P N N N N N N N + + - - - - + - 0.06 0.61 0.374
89 13 FEMALE 4 N N P N N N N N N N N - + + - - + + - 0.671 1.474 0.276
90 45 FEMALE 7 P P P N N N N N N N N + + - - - - - - 0.079 0.192 2.272
91 20 FEMALE 10 N P N P N N N N N N N - + - - + - + + 0.022 1.901 2.241
92 26 MALE 6 P P P N P
malena,haematu
ria
p p p p P - + - - - - - - 0.035 0.356 0.356
93 19 FEMALE 4 P N N N N N N N N N N - + - - - - - - 0.037 0.423 0.267
94 22 FEMALE 4 N N N N N Bleeding gums N N N N N + + - + + - + + 0.038 2.254 1.758
95 23 MALE 5 N N N N N N N N N N P - + - - - - - - 0.03 0.152 0.21
96 19 MALE 5 P P P N P
malena,bleeding 
gums
P P P P N - + - - - - + - 0.024 0.805 0.256
97 14 MALE 3 N P N N N N P N N P N - + - + + - + + 0.2 2.217 2.435
98 17 MALE 7 P P P N P malena P P P N P - + - + - - + - 0.085 2.432 0.345
99 48 FEMALE 4 P P P N N N N N N N N - + - - - - - - 0.025 0.452 0.26
100 32 FEMALE 5 N P P N N N P P P N P - + + + + + + + 0.498 2.153 2.65
